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ABSTRACT 
 
Mutations in genes required for the exocytosis of cytotoxic granules by NK cells and 
cytotoxic T lymphocytes are associated with early-onset familial hemophagocytic 
lymphohistiocytosis (FHL). In this project, we examined how certain missense 
mutations in genes encoding syntaxin-11 and Munc18-2 abolish exocytosis and 
cause disease. Furthermore, we dissected the role of another protein suspected to 
play a role in cytotoxic granule exocytosis, VAMP8.  
In the first study, we characterized an FHL5 patient (Munc18-2 p.Q432X and 
p.S545L) who developed Hodgkin lymphoma with underlying Epstein-Barr virus 
(EBV) infection. The tissue displayed high infiltrates of cytotoxic T lymphocytes 
responsive to EBV-derived peptides, yet the cells had dramatically reduced Munc18-
2 protein levels and were unable to undergo cytotoxic granule exocytosis. The 
patient is an important example of how Munc18-2 missense mutations impairing 
exocytosis can lead to late-onset HLH and, due to decreased immunosurveillance, 
might result in cancer.  
In the second study, we examined the pathophysiological mechanism underlying an 
N-terminal syntaxin-11 mutation (syntaxin-11 p.L58P) associated with FHL4 in three 
unrelated patients. These patients displayed defective cytotoxic granule exocytosis 
despite the functionally important SNARE domain of syntaxin-11 being intact. As the 
p.L58 is an evolutionary conserved amino acid, we hypothesized that the mutation 
interrupts interactions with Munc18-2. Further, we determined whether other 
conserved N-terminal syntaxin-11 residues also contribute to Munc18-2 binding. We 
found that the interaction is dependent on both an intact syntaxin-11 N-terminal 
peptide as well as Habc domain because mutations in either completely abolished 
binding to Munc18-2. It is thus plausible that syntaxin-11, analogous to the syntaxin-
1 / Munc18-1 interaction, employs distinct binding modes to different domains of 
Munc18-2. The interruption of the syntaxin-11 / Munc18-2 interaction could explain 
the reduced syntaxin-11 expression levels. 
Lastly, cytotoxic granule exocytosis is dependent on several proteins being part of 
the fusion complex between a cytotoxic granule and plasma membrane, yet the v-
SNARE mediating granule fusion remains elusive. In the third study, we suspected 
VAMP8 to play a key role in this fusion process. However, VAMP8 did not localize 
to cytotoxic granules but instead to recycling endosomes. Upon T cell receptor 
stimulation, recycling endosomes were recruited to the immune synapse and fused 
with the plasma membrane. As VAMP8 knockdown blocked cytotoxic granule 
release, we hypothesized that VAMP8+ recycling endosomes might deliver an 
important component for the cytotoxic fusion machinery to the plasma membrane. 
Indeed, recycling endosomes transported syntaxin-11 to the plasma membrane, 
with VAMP8 knockdown hampering syntaxin-11 delivery.  
In summary, these data provide a deeper understanding of FHL and the molecular 
mechanisms of cytotoxic granule exocytosis. We describe a possible link between 
FHL and cancer which may have diagnostic, prognostic and treatment implications 
for other FHL patients. Further, we show how N-terminal syntaxin-11 mutations can 
cause disease, with data hinting towards a meticulous series of interaction modes 
necessary for syntaxin-11 maintenance and cytotoxic granule secretion. Finally, we 
find that VAMP8 delivers syntaxin-11 to the immunological synapse in human 
cytotoxic lymphocytes, demonstrating an unexpected role of recycling endosomes 
in cytotoxic granule exocytosis.   
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1 INTRODUCTION  
1.1 THE SIGNIFICANCE OF REGULATED EXOCYTOSIS IN 
DIFFERENT CONTEXTS 
Exocytosis is fundamental to various processes in life. The development of a 
regulated, secretory mechanism which mediates gradable information exchange 
between cells of same or different origin is instrumental for example for movement, 
memory, development, perception of environment, digestion, immunosurveillance –
many mechanisms enabling multicellular forms of life. However, exocytosis is not 
only found in multicellular organisms. Some of the key exocytosis proteins have 
been identified in protozoans, with for example ciliates undergoing both, constitutive 
as well as stimulated secretion [2].  
 
In multicellular organisms, the development is complex, and cellular specialization, 
translating into different cell types, is observed. Morphologically and functionally 
distinct organs can be formed which serve diverse, non-redundant purposes. All 
organs together maintain the whole organism but in order to do so, they need to 
communicate with each other. Exocytosis and, correspondingly, surface-receptor 
based recognition of various types of molecules is one way how cells communicate, 
even over far distances throughout the body. Exocytosis is a particular form of 
membrane-membrane fusion that delivers vesicle-stored molecules to the 
extracellular space (or for integration into the plasma membrane), based on the 
controlled fusion between an intracellular vesicle and the plasma membrane. 
Eukaryotic cells contain a variety of vesicles that serve different purposes. They are 
membrane-enclosed intracellular structures (organelles), which contain and carry 
specific molecules, and hence, different vesicle types have distinguishable molecular 
identities.  Information exchange in the form of membrane fusion (and fission) has to 
occur intracellularly (between organelles), too, for example in order to sort molecules 
to a particular target compartment or pathway. There is a number of protein families 
involved in membrane fusion. Members of these families are implicated in both 
exocytosis and intracellular fusion events.  
 
The molecular mechanisms of exocytosis have been studied intensively with respect 
to neurotransmission, insulin secretion, and some other exocytotic processes, 
representing vital physiological functions. Another intriguing process in which 
exocytosis is crucial is immune defense. A number of cell types are part of the 
immune system. For example, cytotoxic lymphocytes, comprising natural killer (NK) 
cells and cytotoxic T lymphocytes (CTL), are able to recognize and kill infected or 
transformed body cells. They execute this function by releasing specialized secretory 
lysosomes, termed cytotoxic granules, onto the target cell, in order to induce 
apoptosis in that target cell. Defects in lymphocyte cytotoxicity, both with respect to 
granule content and their release, are associated with life-threatening immune 
disorders. A deeper understanding of immune cell effector functions in such disease 
contexts has thus been a longstanding interest in research. 
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1.1.1 Basic components of exocytosis 
Exocytosis is mediated by several families of proteins which all contribute important 
properties to the process. There are proteins which help to transport vesicles 
towards and settle them at the plasma membrane, governing their minute 
organization at the potential fusion sites. Others constitute the protein complex for 
fusion which can force the membranes in very close proximity and support fusion. 
Vesicle localization, fusion complex formation and also recycling of components for 
subsequent rounds of fusion are tightly controlled by a variety of structural, 
regulatory and accessory proteins.  
 
The terminal fusion complex in exocytosis consists of proteins which bear specific 
domains (called SNARE domains, see chapter 1.1.1.1) that can intertwine and form 
a tight helical bundle (called SNARE complex), promoting membrane merger. Such 
proteins (called SNARE proteins as they bear a SNARE domain) are for example 
members of the syntaxin family, VAMPs or members of the SNAP25 protein family. 
Amongst others, proteins of the Munc13 and Munc18 / SM families (no structural 
homologies) are implicated in vesicle docking and priming (preparatory steps 
typically required for membrane fusion), and they influence the interactions formed 
between SNARE proteins. In fact, for example syntaxins and SM proteins can 
undergo a series of distinct interaction modes which greatly determine if SNARE 
complex formation can occur. Also, there are proteins which serve to maintain the 
relative orientation of a vesicle to the exocytosis proteins and the plasma membrane. 
Such structural proteins comprise for example RIMs (Rab-3 interacting molecules), 
RIM-Binding proteins or liprins that can coordinate calcium channels, SNARE and 
Munc proteins and the vesicle via interaction with proteins on the vesicle (for 
example Rab3) or membrane lipids. Besides, there are numerous proteins 
implicated in other fundamental steps throughout exocytosis. These include for 
example calcium sensors which facilitate exocytosis upon calcium binding (for 
example Munc13 proteins or synaptotagmins), or proteins that aid in recycling 
SNARE complex components after fusion (for example NSF or SNAP proteins), and 
many more [3]. 
 
The general principles of membrane fusion are conserved in many cell types, with 
possible modifications according to the individual cell type and vesicle type to be 
exocytosed. To illustrate just one example, as opposed to pre-assembled hot spots 
for docking and exocytosis which are found in some cell types, a study in an insulin-
secreting beta cells line (Ins1 cells) showed rapid de novo exocytosis protein cluster 
formation at subsequent granule fusion sites, and these clusters initiated with the 
proteins Munc18 and syntaxin-1, followed by recruitment of Rab3, SNAP25 and 
Munc13 [4].  
 
1.1.1.1 SNARE complex formation and SM proteins 
For many membrane fusion processes, a SNARE complex forms the basis for the 
merger reaction. The domains within the proteins that mediate this complex 
formation are called SNARE domains. These are alpha-helical stretches of around 
60-70 amino acids, which can form a tight helical bundle, the SNARE complex, 
comprising four SNARE domains provided by several proteins. The SNARE domains 
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zipper up in an N- to C-terminal fashion [5, 6].  SNARE complexes are hydrophobic 
on the inside, except for one ionic layer in the middle of the bundle; where every 
SNARE domain contributes either an R or Q (arginine or glutamine), respectively. 
Accordingly, SNARE proteins can also be classified as R- or Q-SNAREs [7]. VAMPs 
and syntaxins each contain one SNARE domain and SNAP25 proteins possess two.  
One requirement for exocytosis is that the proteins (i.e. their SNARE domains) 
encounter each other in the correct orientation. At the time of fusion, typically, the 
SNAP25 and the syntaxin reside within the plasma membrane (hence also called 
target membrane-SNAREs, t-SNAREs) whilst the VAMP is integrated in the vesicle 
membrane (vesicular SNARE, v-SNARE). SNARE complex formation can force the 
SNARE domains from a previously rather perpendicular to a finally parallel 
orientation in respect to the plasma membrane, and that movement pulls the two 
membranes into very close proximity. This step does not require ATP. The force can 
suffice to overcome the hydrophobic barrier between membranes, and allow for 
fusion. Specificity of SNARE complex formation is not necessarily given by the 
SNARE proteins themselves, as it was observed with arrays of VAMP, SNAP25 and 
syntaxin family members that most of them can promiscuously bind each other [8, 9]. 
However, specificity is, at least in part, regulated by Munc18 proteins [10]. The 
interaction with SM proteins (see chapter 1.4) possibly influences also the trafficking 
of various syntaxins, implicating that subcellular localization could also be a measure 
of specificity regarding syntaxin availability for SNARE complex formation. However, 
SM proteins can often bind several syntaxins. Thus, another aspect determining 
possible SNARE and Munc18 combinations for fusion events is the cell-type specific 
expression pattern of these proteins. 
 
Munc18-1, -2 and -3 proteins belong to the highly conserved Sec1/Munc18 (SM) 
protein family. SM proteins do not possess membrane anchoring domains but they 
can fulfill their function due to interactions with other membrane-targeted molecules 
[11]. The role of SM proteins may exceed docking, as they also facilitate vesicle 
priming and membrane fusion complex formation (i.e. the SNARE complex) [12-16]. 
Munc18-1 for example can bind several proteins, including VAMP2 and VAMP3, and 
a number of other exocytosis-associated proteins [10, 17, 18]. One of the most 
important functions of SM proteins is to support the stability and guide the trafficking 
of syntaxins. The SM protein controls when the syntaxin can interact with other 
proteins of the fusion machinery. More specifically, it permits the syntaxin to adopt a 
more accessible conformation when SNARE complex formation has to occur. Thus, 
SM proteins are frequently termed chaperones for syntaxins, and they fulfil an 
essential role during exocytosis. Munc18-1, syntaxin-1 and a range of other proteins 
are central to neuronal exocytosis, and their absence can produce dramatic 
phenotypes. In immunology, exocytosis represents a central mechanism enabling for 
example eradication of tumors or infected cells. When genetic linkage analyses were 
performed on patients suffering from a severe hyper-inflammatory syndrome (familial 
hemophagocytic lymphohistiocytosis, FHL) [19-23], surprisingly, it turned out that 
some of the genes mutated in such patients encode homologues to some of the key 
exocytosis proteins identified in other model systems for exocytosis. In fact, 
mutations in the immunological pendants to the neuronal proteins Munc18-1, 
syntaxin-1 and Munc13-1 were all linked to FHL (see chapter 1.3). Hence, it is likely 
that homologous molecular machineries operate in cytotoxic lymphocytes to regulate 
the release of cytotoxic components from such immune cells, and that these proteins 
are non-redundant for cellular cytotoxicity. It is essential to gain insights on the 
molecular processes governing cytotoxic granule exocytosis so we can better 
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understand disease-causing mechanisms of FHL mutations, and relate this specific 
type of secretion to other exocytotic processes.  
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1.2 CYTOTOXIC LYMPHOCYTES 
Cytotoxic lymphocytes comprise cytotoxic T cells and NK cells. Both cell types are 
able to adhere to and directly kill aberrant cells in a cell-contact dependent manner. 
However, they differ in various ways, for example in regards to their development, 
the type of antigenic structure they recognize and, coupled to this, the pool of 
antigen specificities they encompass, their ability to form memory pools and some 
other criteria. Hence, they have historically been assigned to different branches of 
the immune system, with NK cells allotted to the innate immune system and CTL to 
the adaptive immune system. 
 
 
1.2.1 Innate and adaptive immunity concepts 
Our immune system is omnipresent, multilayered and highly adaptable. It protects 
the body from long-lasting consequences of tissue damage caused by injury, 
infection, inflammation, cancer or other pathologic conditions. The cell types that 
contribute to the immune system comprise amongst others megakaryocytes and 
their progeny (platelets, also called thrombocytes), granulocytes (basophils, 
neutrophils and eosinophils), dendritic cells, monocytes and macrophages, mast 
cells and lymphocytes (B, T and NK cells). But also other cells, for example 
endothelial cells, can shape and support immune responses, for example via 
secretion of soluble factors or by supporting or limiting migration from the blood 
stream into surrounding tissues. Classically, the immune system has been divided 
into innate and adaptive immunity. The distinction is based on whether a cell type is 
able to adapt to the antigen it recognizes throughout an immune response, and 
whether a response is specific for the antigen. Further, the ability to undergo clonal 
expansion (followed by contraction) and formation of a memory pool of these 
antigen-specific cells has been seen as a hallmark. Based on these broad 
definitions, granulocytes, dendritic cells, mast cells, monocytes, macrophages and 
NK cells were defined as innate immune cells. On the other hand, T and B cells were 
ascribed to be part of the adaptive system.  
 
T and B cells rely on somatically recombined gene segments which are fused 
together and generate the T cell receptor (TCR), or B cell receptor (BCR) molecules, 
respectively. This process is known as the V(D)J gene segment recombination. The 
resulting TCR or BCR gene product is, simultaneously to end-joining of the V, D and 
J segments, further modified by random (non-templated) addition of individual 
nucleotides between the segments. Thus, an immense diversity of genetically 
rearranged TCR and BCR molecules is generated, providing a huge number of 
antigen specificities. The enzymes which mediate this DNA-modifying process 
comprise RAG enzymes and TdT. Also, during the course of an adaptive immune 
response, gene segments encoding BCR variable regions can undergo further 
modification known as somatic hypermutation. For that, key enzymes include the 
DNA deaminase AID and error-prone DNA polymerases. For B cells, the receptor 
affinity-based selection process occurs in germinal centers of lymph nodes and is 
assisted by follicular helper T cells. There, the B cells undergo further modification of 
the BCR by class switch recombination which turns the membrane-bound BCR into 
a soluble immunoglobulin with same antigen specificity but different isotype (distal 
 6 
 
part of the antibody) [24, 25]. In the case of T cells, the TCR protein complex is not 
known to undergo somatic hypermutation in the same way as the BCR. However, T 
cells can undergo a process termed priming. It refers to naïve T cells being less 
responsive to stimuli than primed cells. Priming occurs when the naïve T cell is 
activated via TCR engagement with peptide-loaded MHC complexes (pMHC) and 
simultaneously via co-stimulatory receptor engagement, such as CD28 or CD8, as 
well as co-stimulation via pro-inflammatory cytokines such as IL-2 or IFN-alpha [26]. 
 
As far as is known today, NK cells do not undergo somatic recombination, 
hypermutation or priming processes and as such do not “adapt” to their trigger. 
However, in mice infected with murine CMV, responsive NK cells were able to mount 
memory-like expansion and recall responses [27]. Also, NK cells can mount an 
antigen-specific memory-like response in SIV-infected macaques [28]. Furthermore, 
in humans it has been shown that infection with CMV promotes expansion of specific 
NK cells subsets which present with differential signaling protein expression, altered 
epigenetic states and they can also display different functional capacities. Such cells 
can persist for a long time, and can even be protective against relapse of leukemia in 
patients who had undergone hematopoietic stem cell transplantation [29, 30]. Hence, 
memory formation may be an inherent property to NK cells. Based on such data, the 
classic definition of NK cells being part of the innate system has begun to be re-
evaluated. Of note, other innate immune cells have also been observed to mount 
stronger recall responses without irreversible somatic changes in their DNA or clonal 
expansions upon antigen encounters [31]. The concept of trained immunity refers to 
a variety of innate immune cells which after pathogen encounter can undergo 
changes in metabolism and possibly epigenetic states which allows them to 
generate a stronger response to a pathogen if they encounter it again. 
 
 
1.2.2 Cytotoxic T lymphocytes 
T cells are derived from the common lymphoid progenitor in the bone marrow, and 
develop further in the thymus. T cell lineage commitment starts with recombination 
and surface expression of the TCR. Cells that recombine a productive TCR 
simultaneously upregulate the co-stimulatory receptors CD4 and CD8 and are then 
termed double-positive (DP) T cells. Depending on affinity for either MHC class I or 
II, T cells downregulate CD4 or CD8, respectively. Following commitment to the 
CD4+ or CD8+ T cell lineage, the cells undergo positive and negative selection 
aided by thymic epithelial cells which present self-antigens. This ensures that cells 
with a TCR interacting too strongly or too weakly are not released into the periphery 
and instead undergo apoptosis. For the organism this selection process is crucial as 
it ensures that no self-reactive or entirely non-reactive T cells are maintained. After 
selection, the naïve CD4+ and CD8+ T cells leave the thymus. In lymph nodes cell 
activation and maturation can occur. Antigen recognition by CTL is dictated by the 
TCR. After MHC class I –associated antigen presentation, a CD8+ T cell specific for 
that particular antigen can upregulate perforin and reach full cytotoxic capacity. Such 
a cell can then undergo clonal expansion and migrate to peripheral tissues in order 
to find the site of infection. CTL contain cytotoxic granules harboring perforin, 
granzymes and other molecules, similar to NK cell cytotoxic granules – although 
granule protein abundances can vary between cytotoxic NK cells and CTL. Besides, 
cytotoxic granule content also varies between differentiation stages, and, 
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corresponding to the gain in cytotoxic capacity, in mice it was reported to change 
with the number of proliferation rounds in CTL [32-34]. 
 
Just like healthy cells presenting self-peptides (not immunogenic) on their MHC 
molecules all the time, infected body cells can present cytoplasmic pathogen (or 
tumor) -associated peptides on their cell surface, typically bound to MHC class I 
molecules. Such peptides are 8-10 amino acids long. They are generated via 
intracellular processing of proteins through the proteasome and non-proteasomal 
peptidases [35]. The cytoplasmic peptides are transported through a transporter 
system (TAP) into the lumen of the ER where they can be loaded onto MHC class I 
molecules. The secretory pathway delivers the pMHC complexes to the plasma 
membrane, where they present the antigen to the extracellular space, for recognition 
by CTL.  
 
Differences in the quality of TCR-pMHC interactions yield variable outcomes in 
different settings. The interaction strength for example influences T cell 
differentiation. It was shown that mice which have only few and weakly interacting 
TCRs had normal levels of T cells with a TCR composed of  and  chains, whereas 
 T cells were reduced in numbers and showed impaired differentiation [36]. 
Another study found that low signaling strength of TCRs (measured in numbers of 
functional ITAM motifs in the associated CD3 molecules) yielded cytokine secretion 
whereas high signaling strength was needed to drive proliferation [37]. Along these 
lines, a study on CD4+ T cells showed that engagement of one single TCR was 
enough to mount cytokine production, and one interaction seemed enough to trigger 
a slow but long-lasting TCR clustering [38]. However, to form a stable synapse in a 
CTL, around ten TCRs needed to be engaged, whilst killing required engagement of 
only three TCRs, and thus a stable synapse may not always be required for killing a 
target cell [39]. Besides that, it was shown that signal propagation in the T cell is 
dependent on continuous engagement of the TCR as well as the actin cytoskeleton 
[40, 41]. There has been great interest in terms of TCR-pMHC interaction strength 
regarding prediction of successful cytotoxic events (for example [42, 43]). If the 
interaction is strong, supposedly cytotoxic granule exocytosis, followed by target cell 
killing could occur. However, despite some controversy in the field, one notion is that 
the bond lifetime is more critical than bond strength, although both parameters will 
determine the outcome. The bond strength was even found to negatively correlate 
with activation potency [42]. A possible explanation for this was discussed in the 
article: Following the concept of serial triggering [40, 44], the T cell has to quickly 
scan countless numbers of pMHC on the potential target surface, obviously also 
encountering many pMHCs loaded with peptides that the T cell is not specific for. It 
has been seen that pMHCs recognized by a TCR can engage and stimulate multiple 
TCRs serially. The authors speculated that there likely is an optimum combination of 
interaction strength and duration, with too short but numerous interactions being 
insufficient for TCR triggering, and fewer but longer-lasting interactions preventing 
serial triggering and initiating prosperous TCR signaling and synapse formation. 
However, prolonged TCR signaling is also well known to lead to internalization of the 
TCR signaling complexes which intriguingly was shown to be accompanied by 
prolonged signaling, up to 10 h after internalization [45]. The internalization is 
indispensable for T cell function, though hard to reconcile with continuous pMHC 
engagement supporting signaling. Dynamin-2 knockout mice (which cannot 
internalize TCR) presented with reduced TCR signaling strength and impaired 
proliferation [46]. Besides the complicated kinetics and internalization of TCR, a third 
layer of regulation is found over the different regions of the contact area [41]. The 
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authors observed that TCR clusters tend to move towards the center of the contact 
site, where they eventually stop signaling and get downregulated (for recycling or 
degradation) whereas peripheral TCR clusters keep forming and signaling. A 
suggested explanation could be the protection from excessive activation potentially 
yielding cell death. Due to high antigen sensitivity as well as massive signal 
enhancement the T cells need to control the signaling input carefully despite being 
dependent on continuous input for response generation.  
 
 
1.2.3 Natural killer cells 
The name “natural killer” cell originates from the observation that a subpopulation of 
lymphocytes could kill susceptible target cells without prior priming [47-49]. However, 
it is meanwhile known that NK cells can undergo various differentiation and 
education stages, and these do not harbor equal cytotoxic reactivity. The notion that 
NK cells are, besides their role in tumor surveillance, also pronouncedly connect to 
immunity against viruses (particularly Herpes viruses) was supported by various 
patient reports where NK cell dysfunction co-occurred with high susceptibility to viral 
infections (for example [50-57]. One important case is an NK cell deficient patient 
described in 1989 [58]. The patient had recurrent viral infections and was found to be 
devoid of NK cells and NK cell lytic activity and turned out to suffer from a 
heterozygous GATA2 mutation. Haploinsufficiency of this hematopoietic transcription 
factor can cause variable clinical presentations, to a certain degree reflecting paucity 
in different immune cell subsets. Besides NK cells, deficiencies in monocytes, B cells 
and dendritic cells typically develop in GATA2 patients [59]. 
 
NK cells develop in the bone marrow from common lymphoid progenitor cells. NK 
cell development comprises several phenotypically different stages. The NK cells 
that leave the bone marrow have lost early developmental markers such as CD34 or 
CD45RA, and most of them have acquired for example CD56 (frequently used as 
NK cell marker), granzymes and perforin. After this, they can differentiate further into 
functionally and phenotypically distinct subsets. Some models suggest that there is a 
progression from CD56bright NKG2A+ KIR- CD16- CD57- (uneducated, barely 
cytotoxic, hyporesponsive NK cells) towards CD56dim NKG2A- KIR+ CD16+ CD57+ 
(educated, cytotoxic, mature NK cells). The stages in between, broadly spoken, 
could comprise loss of NKG2A and gradual acquisition of one or more KIR 
receptors, CD16, perforin and later on CD57 [60, 61] although this is not completely 
clear to date. Of note, molecular barcoding of immune cells in macaques has raised 
the question if CD56bright cells in humans are precursors of CD56dim cells, or - as 
the macaque data suggests - rather an independent NK cell subset [62]. Further 
research will hopefully provide a deeper understanding of human NK cell 
development. 
 
In order to sense aberrant cells, NK cells possess a variety of activating and 
inhibitory, germline-encoded surface receptors. The sum of all instant activating and 
inhibitory input determines how reactive an NK cell is towards a potential target 
rather than one receptor dominating every single encounter. It has been noted early 
on that cells deficient in ligands for NK cell inhibitory receptors (such as inhibitory 
KIR) are more susceptible to being killed by NK cells, although it became clear that 
absence of inhibitory interactions is mostly not enough to induce NK cell killing. NK 
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cell-resident inhibitory KIR molecules can bind to pMHC, on an opposing cell. Most, 
but not all body cells are protected through expression of MHC class I. For example, 
red blood cells do not express MHC class I. However, these possess other 
protective molecules, such as CD47, which mediate a “let me live” signal to myeloid 
and NK cells. CD47 additionally might have a role in NK and T cell homeostasis in 
vivo [63-65]. Due to the notion that, based on MHC class I expression, NK cells 
sense “self” and are prone to attack surfaces devoid of inhibitory ligands, the Missing 
Self-hypothesis was formulated [66]. It reminds of and remotely relates to the term 
Altered Self, which describes the concept that T cells, recognizing antigens via their 
T cell receptor (TCR), can only be activated through binding to self-MHC molecules 
which have been “altered” by the bound peptide. [67, 68]. However, it was also 
observed that certain KIR receptors show peptide selectivity in relation to MHC class 
I presentation. Thus, also for NK cells the concept of Altered Self has been 
discussed. [69]. Further, it has become clear that NK cells need to undergo an 
education process which is based on inhibitory (for example inhibitory KIR) receptor 
– ligand interactions. The quality and number of effector functions as well as the 
number of responding NK cells was shown to increase upon enhancement of 
inhibitory interactions in mice [70, 71] and humans [72, 73]. It should be noted that 
also other inhibitory receptors, such as the NKG2A/CD94 heterodimer, shape the 
KIR-MHC educated NK cell pool [74]. NK cells can not only express different 
numbers of KIR receptors (or none) but they can also differ in terms of which 
activating receptors they express (even though that is more homogeneous 
throughout the NK population). A mass cytometric screen of monozygotic twins and 
healthy controls revealed that the inhibitory receptor repertoire in human NK cells is 
mostly determined by genetics whereas the activating receptor expression is mostly 
shaped by environmental influences [75]. 
 
Activating NK cell receptors comprise the IgG receptor CD16 (FcγRIIIA, recognizes 
Fc parts of IgG molecules; mediates “antibody-dependent cellular cytotoxicity”, 
ADCC), NKG2D (recognizes stress ligands of the ULBP family, and MICA and –B), 
NKp30, -44 and -46 receptors (recognize viral, bacterial and parasitic epitopes; partly 
unknown), DNAM-1 (recognizes polio virus receptor (PVR) components), activating 
KIRs and NKG2C. NKp44 is only found on cytokine-activated cells though [76]. KIRs 
recognize classical molecules of the MHC class I family (HLA-A, -B, and –C 
molecules) whilst NKG2C binds to the non-classical MHC class I molecule HLA-E. 
[77]. Other activating receptors on NK cells include integrins such as LFA-1, and 
SLAM family receptors, for example 2B4 (CD244), CD48, NTB-A or CRACC. Some 
of these activating receptors can synergize to mount potent cell activation and 
cytotoxic responses [78, 79]. Of note, mutations in FCGR3A encoding CD16 [50, 51, 
80] have been associated with immunodeficiency, as these patients suffered from 
recurrent viral (Herpes family) infections, and some had reduced NK cell numbers. 
Interestingly, none of the patients displayed impaired antibody-dependent 
cytotoxicity. However, some presented with reduced killing of the susceptible K562 
cell line. One study [80] found wt CD16 to be associated with CD2 at the synapse, 
which was reduced for a mutant protein. The loss of CD2 association could account 
for lower adhesion and signal transduction in these patients, resulting in less efficient 
cytotoxicity. 
 
As a side remark, it is worth considering that there are populations of NK cells 
presumably dedicated to other purposes than killing. Uterine (decidual, dNK) NK 
cells (and macrophages) were found to play important roles in remodeling the 
decidual vasculature [61, 81, 82]. dNK were shown to mediate poor cytotoxicity 
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against susceptible target cell lines and they formed contact sites which did not 
progress to cytotoxic granule polarization [83]. It is currently discussed which role 
dNK play in pregnancy, embryo survival and how the KIR-HLA gene setting 
contributes to implantation depth of the trophoblast / placenta which could in turn 
regulate nutrient and oxygen availability for the fetus [84].  
 
 
1.2.4 Receptor signaling and synapse formation  
Despite different modes of target cell recognition, the late steps leading to CTL or NK 
cell killing of a target cell are highly similar, or even equivalent, as they rely on the 
same molecular machinery. When cytotoxic lymphocytes recognize susceptible 
target cells, they form a tight conjugate with them and eventually induce apoptosis 
(intrinsic cell death) in the target. Such targets can be tumor cells or infected cells 
which can present pathogen-derived peptides on their surface, display an altered 
surface expression of MHC class I molecules or upregulate stress-induced surface 
proteins. If a pathogen does not interfere with surface presentation of MHC class I, a 
CTL may react to it, whilst if it down-modulates pMHC presentation, this could call to 
the attention of NK cells.  
 
The TCR consists of several subunits. In CTL recognizing pMHC class I, it is 
composed of  and  chains. The TCR is associated with CD3, a multi-chain 
complex consisting of  and  subunits. All intracellular CD3 complex chains 
harbor functional peptide motifs called ITAMs. How exactly the signal is initiated 
once the TCR is engaged, is still not clear, possibly several mechanisms act 
simultaneously [85]: TCR engagement can trigger a conformational change in the 
CD3 complex followed by release of the ITAM motifs from the plasma membrane, 
making them accessible for phosphorylation. Also, signaling is possibly initiated by 
the tight binding to the target cell surface which physically excludes large regulatory 
phosphatases from the contact site (such as for example CD45). The signal 
transduction over the membrane induces recruitment of non-receptor protein 
tyrosine kinases of the Src family which then phosphorylate the CD3 ITAM motifs. 
Similarly, NK cell receptors which are coupled to ITAM signaling, initiate Src kinase 
activation. Such NK cell receptors on are for example CD16, NKp30, Np44 or 
NKp46. ITAM signaling enables binding and phosphorylation of ZAP70 which can 
activate LAT and Slp-76, and also, via activation of Grb2, MAP kinase signaling can 
be initiated. This in turn for example leads to ERK phosphorylation and changes in 
gene expression liked to cell activation [86-88]. Other NK cell receptors which do not 
signal through ITAM motifs comprise the integrin LFA-1, 2B4 or NKG2D. These 
receptors can also initiate MAP kinase signaling, in the case of 2B4 PLC activation, 
or in the case of NKG2D activation of PI3K and mTOR [88]. ITAM signaling also 
leads to activation of PLC and this enzyme can hydrolyze phosphatidyl-inositol-2-
phoasphate (PIP2) to diacylglycerol (DAG) and inositol-1,4,5-trisphosphate (IP3). 
IP3 is soluble and diffuses to the ER membrane where it binds to IP3 receptors and 
opens them to allow calcium to pass through.  
 
Calcium fluxes from the ER into the cytoplasm. IP3 is not opening plasma 
membrane resident calcium channels [89]. The ER calcium depletion is sensed by 
ER-resident transmembrane STIM1 proteins which oligomerize, change 
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conformation and reorient towards the plasma membrane site (where the activation 
occurred), where they open store-operated calcium channels consisting of Orai1 [90-
93]. This results in further calcium influx from the extracellular medium. The process 
is termed store-operated calcium entry, SOCE. STIM1 and ORAI deficiencies are 
associated with erroneous calcium sensing and SOCE. The lymphocytes can still 
recognize target cells, activate the integrin LFA-1 and polarize the cytotoxic 
granules, but exocytosis and target cell killing are reduced. Also cytokine production 
was shown to be reduced [94-97]. Calcium binds to several proteins, amongst others 
to calcineurin. This phosphatase then targets cytoplasmic NFAT leading to nuclear 
translocation of this transcription factor. Another protein activated by calcium binding 
is calcium calmodulin-dependent kinase, again initiating transcription factor 
activation [98]. 
 
DAG remains in the plasma membrane where it recruits protein kinase C (PKC).  
PKC activation at the site of cell activation has been linked to MTOC reorientation 
[99] which is important for polarized cytotoxic granule exocytosis in lymphocytes. 
DAG-activated PKCs were suggested to act through a reciprocal positioning of 
dynein and myosin proteins which ensure pulling/pushing forces that orient the 
MTOC towards the contact site [100]. PKC enzymes have also been implicated in 
regulating cell protrusions and microtubule stability in T cells under shear flow 
conditions [101]. That is interesting because it might implicate that PKC enzymes are 
important for cytoskeleton-dependent organelle positioning events in different 
settings. Of note, several genes regulating cytoskeletal elements, mostly actin, have 
also been linked to primary immunodeficiency. These are for example the genes 
WASP and WIPF1 (associated with WAS), DOCK8 (associated with autosomal 
recessive hyper-IgE syndrome and abnormal morphology and deformation during 
tissue migration of lymphocytes, [102]), ITGB2 or FERMT3 (associated with 
leukocyte adhesion deficiencies). Integrin as well as Src kinase signaling were both 
implicated in cytotoxic granule convergence to the MTOC, as well as the subsequent 
MTOC+granule polarization towards the immunological synapse [103-105]. The 
integrin-linked kinase (ILK) was found to transduce the integrin signal onto the 
MTOC via a network of signaling transducers comprising for example paxillin, 
PTK2B, Cdc42, APC and CLIP-170 [106]. Abrogation of components of this 
signaling network yielded abrogation of cytotoxic granule polarization. Also, the 
granule convergence could be triggered by pro-inflammatory cytokine stimulation 
(here IL-2), as well as target cell stimulation, and it was found to be independent of 
actin and microtubule reorganization events, but dependent on motor protein dynein. 
Further, cytotoxic granule recruitment to the MTOC was mechanistically not coupled 
to cytotoxicity [104, 105]. Synapse formation and recruitment of the MTOC with the 
associated cytotoxic granules is essential for polarized secretion.  
 
Not all NK cell receptors trigger the entire cascade. Experiments activating single 
receptors have shown that for example pure integrin (LFA-1) engagement leads to 
granule polarization but not secretion, whilst isolated CD16 stimulation provokes 
cytotoxic granule release which is not polarized [107]. Also, it has been observed 
that many receptors cannot initiate cytotoxicity on their own in resting cells. 
Interestingly, they gained function when the cells were IL-2 stimulated. Of note, IL-2 
also increases the expression level of many of these receptors. Such receptors, for 
example NKp46, NKG2D, 2B4, DNAM-1, or CD2 can also trigger cytotoxicity in 
resting cells when they are co-stimulated together with other receptors. One 
example is synergistic co-stimulation via NKp46 and NKG2D. Several other 
synergistic receptor combinations have been identified [79]. 
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The signaling cascades initiating cytotoxic granule release can under some 
experimental conditions establish a large, organized landscape of signaling clusters 
at the site of activation: The immune synapse. A very schematic illustration of the 
immune synapse suggests that the synapse can be structured in a concentric 
fashion, with the rings being distinct supramolecular activation clusters (SMAC). The 
innermost area (central SMAC, cSMAC) comprises TCR (or NK cell receptor) 
signaling clusters which organize the actin mesh under the membrane. The next ring 
(peripheral SMAC, pSMAC) would then harbor adhesion molecules such as 
integrins, or proteins linking surface receptors with the cytoskeleton, for example 
talin. A more distal ring (dSMAC) would then contain spatially demanding, or 
regulatory molecules such as CD45 [108]. However, one should note that this model 
describes a structural frame for the subsequent exocytosis process, but not all 
synapses are perfectly round or adopt this exact architecture. Very low numbers of 
TCR molecules are actually needed to trigger exocytosis, and also some other 
observations demand a more careful synapse region definition. For example, CD45 
was not only found in  the peripheral synapse areas but was also observed in the 
very center of the cSMAC by some authors [109]. Also, TCR signaling might in fact 
preferentially occur in the distal synapse area and be reduced in the central domain 
[41]. It is thus possible that the cSMAC might mainly be the site of TCR 
downregulation and cytotoxic granule exocytosis. Spatial constraints could affect the 
cSMAC but maybe even more pronouncedly the pSMAC where tight adhesion is 
established. Novel TCR signaling clusters could continue to form in the dSMAC, 
cross the pSMAC and progress to down-modulation once they are in the cSMAC. 
For NK cells, the immune synapse may also not always be as stringently organized, 
or the exclusive site of cytotoxic granule release. Some types of receptor-induced 
cytotoxic granule exocytosis may occur at regions outside of the contact site. This 
could for example be the case during the non-polarized degranulation following 
CD16 stimulation [107]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 13 
 
1.3  (FAMILIAL) HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS: 
CLINICAL ASPECTS 
To date, there are numerous genetic aberrations documented which are causally 
linked to immunological disease and hence are classified as primary 
immunodeficiencies (PID). PID is a group of diseases which impair either 
development or function of the immune system. The genes as well as the disease 
phenotypes are variable, and most genetic variants or mutations affect more than 
one particular cell type. PID patient cells provide an important opportunity to gain 
essential insights into disease-causing mechanisms of aberrant proteins, and also 
do they often unveil crucial mechanistic details about the wt proteins.  
 
Hemophagocytic lymphohistiocytosis (HLH) is a hyper-inflammatory syndrome which 
can manifest in variable symptoms. It can occur as consequence of an underlying 
genetic cause (FHL), but also as a secondary disease as complication of malignant, 
rheumatoid or infectious diseases. Epstein-Barr virus (EBV) infections are very often 
noted in HLH patients [110-112], but also other viruses possibly linked to the disease 
have been found in HLH patients, such as Herpes simplex viruses [113, 114], 
Varizella zoster [115], Dengue virus [116], parainfluenza virus [117], avian influenza 
virus or co-infections (for example with fungi or bacteria) in HIV-infected individuals 
[118, 119]. Also, some bacterial infections were suspected to be associated with 
HLH development, such as for example Acinetobacter baumannii [120] or 
Mycoplasma pneumoniae [121]. Similarly, some parasitic infections can trigger HLH, 
mostly reported in patients suffering from visceral leishmaniasis [122, 123]. 
 
The name of the disease is derived from the 
observation that in bone marrow aspirates of 
some HLH patients, activated tissue 
macrophages (histiocytes) engulf and digest 
erythrocytes, lymphocytes and other 
hematopoietic cells and precursors (Figure 
1). However, this is not observed in all 
patients. The current list of diagnostic 
markers comprises prolonged periods of 
fever, splenomegaly, cytopenias in at least 
two blood cell lines, enhanced triglycerides, 
soluble CD25 and ferritin, reduced fibrinogen, 
low or absent NK cell activity [124]. Fulfilment 
of 5 of these criteria leads to the diagnosis 
HLH. This diagnostic system is necessary 
since none of the criteria is specific for HLH. 
Besides these, many HLH patients present 
with neurological or gastrointestinal 
abnormalities. Colitis, diarrhea, convulsions, 
loss of consciousness, confusion, irritability, 
cranial nerve palsies, hearing losses and 
seizures in the CNS have been reported, 
amongst others [125-129]. Of note, HLH 
patients with neurological involvement 
presented with a decreased life expectancy 
[130]. 
Figure 1. Hematoxilin-Eosin staining of 
bone marrow  from HLH patients showing a) 
histiocytes phagocytosing erythrocytes and 
lymphocytes and b) phagocytic cells 
containing erythrocytes and platelets. [1]  
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The treatment of HLH typically comprises immunosuppressive / chemotherapeutic 
drugs (eg. cyclosporine A, anti-thymocyte globulin, etoposide (also known as VP16), 
teniposide) in combination with corticosteroids, such as dexamethasone or 
prednisone [124]. The treatment aims at controlling activation and expansion of 
lymphocyte populations (and other hematopoietic cells, such as histiocytes) causing 
tissue pathology and enhancing the risk for ultimate multi-organ failure. Such 
treatments greatly improve the clinical symptoms of HLH. In the case of FHL, the 
only cure is allogeneic hematopoietic stem cell transplantation. A number of genes 
have been associated with FHL (Table) but the list might grow, incorporating genes 
that play non-redundant roles in cytotoxic granule exocytosis, but in which mutations 
are not embryonically lethal. Currently, four genes are associated with FHL. Some 
other genes are linked to similar clinical pictures as FHL, and thus they are often 
termed FHL-like. They comprise for example Chediak-Higashi syndrome or Griscelli 
syndrome type 2. 
 
 
Primary 
Immunodeficiency 
Chromosomal 
location 
Gene Protein 
FHL-1 9q21.3-q22 Unknown Unknown 
FHL-2 10q21-22 PRF1 Perforin 
FHL-3 17q25 UNC13D Munc13-4 
FHL-4 6q24 STX11 Syntaxin-11 
FHL-5 19p13.2-3 STXBP2 Munc18-2 
CHS 1q42.1-q42.2 LYST Lyst 
GS-2 15q21 RAB27A Rab27a 
XLP-1 Xq25 SH2D1A SAP 
XLP-2 Xq25 XIAP XIAP 
HPS-2 5q14.1  AP3B1 AP3 
Table. Primary immunodeficiencies resulting in HLH and HLH-like disease. Abbreviations: FHL: 
Familial hemophagocytic lymphohistiocytosis, CHS: Chediak-Hiagshi syndrome, GS-2: Griscelli 
syndrome type 2, XLP: X-linked lymphoproliferative syndrome, HPS-2: Hermansky-Pudlak syndrome 
type 2. Modified from [131, 132]. 
 
In the case of FHL, the disease is presumably triggered by an immunological event, 
often an infection with viruses of the Herpes family. Many FHL patients are EBV or 
CMV-positive. Once an initial inflammatory response has been generated, a 
systemic HLH flare might follow and the patient deteriorates rapidly. HLH pathology 
is thought to be due to massive and continuous activation of cytokine- and 
chemokine-producing cells which cannot eradicate pathogenic triggers. One study in 
knockout (KO) mice showed that absence of granzymes A+B, or perforin, 
respectively, yields enhanced cytokine and chemokine release from CTL and NK, 
upon target encounter. Such supernatants were able to induce robust IL-6 
production in syngeneic macrophages in an IFNg-dependent manner. The authors 
delineated that the increased activation and cytokine production is driven by the 
inability to detach from the target cell – as they cannot be killed by the KO 
lymphocytes. This yields prolonged conjugate time and repeated calcium flux [133]. 
These findings could potentially explain the abnormally high amounts of pro- and 
anti-inflammatory mediators found in plasma and tissues, and these in turn the fever 
flares. The lymphocytes would get overly activated upon an initial trigger, produce 
high amounts of cytokines which can stimulate various other cell types, start surface 
expression and at some point shedding of CD25, upregulate adhesive molecules 
and start invading different tissues such as liver, kidneys or even brain. A systemic 
state of pathologic inflammation can be the result. The cytokine storm does not only 
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lead to fevers, but some cytokines such as TNF or IFN, may impair hematopoiesis 
[131], which can contribute to the cytopenia seen in many patients. A study in 
perforin KO mice infected with LCMV has shown that the hyper-inflammation 
induces a shortage of free IL-2 [134]. That is a result of elevated CD25 surface 
expression on activated CD8T cells, shed CD25 and also decreased IL-2 production 
of CD4T cells. In the perforin KO mice, over the course of the disease, the IL-2 
shortage lead to decreased surface CD25 expression and abnormal contraction of 
regulatory T cells. The residual IL-2 was shown to be consumed predominantly by 
activated CD8T cells, maintaining the high activation and proliferation state, and thus 
over time partially uncoupling the ongoing hyperinflammation from the (often 
infectious) initial trigger. Besides these processes, the elevated cytokines also 
activate macrophages to clear immune and red blood cells, which can lead to the 
phagocytic histiocytosis. This can further drive the cytopenia observed in blood, 
combined with the increased tissue invasion of lymphocytes and other immune cells. 
The elevated cytokines can also lead to inhibition of lipoprotein lipase and increase 
production and secretion of triglycerides [131]. Activated macrophages can secrete 
ferritin and other factors which can decrease fibrinogen levels. Overall, these 
processes sum up to imbalances in immune cell populations and an overall massive 
activation of multiple cell types. 
 
Of note, another mechanism which could promote FHL pathology is a possible link 
between the massive cell activation and Toll-like receptor (TLR) activation. In a 
mouse model of FHL (Unc13d knockout (jinx) mice, infected with LCMV), one group 
studied whether the hyper-inflammatory state could be alleviated if certain proteins 
supporting inflammatory processes would be targeted. Interestingly, they found that 
a key signaling molecule implicated in TLR signaling, MyD88, was substantial for the 
development of the HLH-like syndrome [135]. In line with this, another report 
studying genetically normal mice found that consecutive stimulation of TLR9 results 
in an aggressive inflammatory state as well, resembling HLH [136]. More detailed, 
that stimulation led to macrophage activation syndrome, MAS. MAS shares several 
clinical features with HLH. Common are for example elevated cytokine levels, 
activated macrophages and a high inflammatory state. Hence, innate immune 
receptor signaling (TLR signaling) could powerfully contribute to the HLH pathology 
seen in FHL patients. Many mechanisms occur simultaneously in HLH and probably 
together drive the pathology which remains unsolved and is fatal unless treated. 
However, if the inflammatory trigger could be controlled in the beginning, a hyper-
inflammatory state could be prevented. Thus, cytotoxic granule exocytosis is 
fundamental for FHL pathology. 
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1.3.1 Severity of FHL / HLH and association with malignancies 
Interestingly, depending on which gene is affected, HLH onset and severity can have 
different kinetics. It was shown in patients and in FHL gene mouse models (infected 
with CMV) that on average there is a hierarchy of pathology and morbidity. There 
was a gradient of perforin > Rab27a > syntaxin-11, looking at age of onset (patients), 
survival, production of IFN, TNF and IL-1 (mice), with loss of perforin being the 
most severe. However, all mice presented with comparable target killing deficiency, 
CMV load, loss of body weight, overall decline of white and red blood cells as well as 
platelets [137]. This is in line with a report on genotype-phenotype correlations 
comparing syntaxin-11 and perforin deficient patients which found earlier onset for 
FHL2 as opposed to FHL4 patients [138]. Another study included mouse models for 
perforin, Rab27a, syntaxin-11, AP3 and Lyst deficiency as well as patient data. They 
found a similar gradient of severity of the affected proteins mentioned above, with 
the Lyst patients revealing later age of onset than syntaxin-11 and, dependent on the 
mutation, almost normal degranulation and cytotoxicity in some of the mice (beige 
mice). However, another Lyst mouse model (souris mice) was as detrimental as the 
ashen mice, which represents Rab27a deficiency. The mouse model for AP3 
deficiency (pearl mice) displayed an intermediate severity [139]. A mouse model for 
Munc13-4 deficiency (jinx mice) displayed development of HLH-like symptoms upon 
mouse arena virus LCMV infection, but other pathogens which can trigger HLH in 
other FHL mouse models such as Listeria monocytogenes or herpes virus MCMV 
infection did not produce a robust representative HLH picture. Also, these mice did 
not suffer from neutropenia [140]. The jinx mice may thus only be a good model 
system in combination with a carefully chosen pathogenic trigger. Munc13-4 
deficient patients, carrying homozygous or compound heterozygous mutations, 
present early in life with clinical symptoms (< 24 months), comparable to perforin 
homozygous / compound heterozygous patients [141]. Most of them have normal 
perforin expression, but the degranulation defect is comparably severe to Munc18-2 
patients.  
 
Besides the gene affected, there is evidence [141-
143] that accumulation of heterozygous FHL 
mutations (in different FHL genes) increases the 
risk to develop HLH in mice and humans. 
Interestingly, when looking at the clinical records of 
FHL gene carriers (monoallelic relatives of FHL 
patients), one report found an increased risk of 
developing malignancies in female relatives of the 
first generation [144]. In fact, there are several 
reports possibly linking immunodeficiencies, 
malignancies and viral infections, such as EBV 
[145]. A co-occurrence between monoallelic 
mutations in perforin and lymphoma (Anaplastic 
large cell lymphoma) development was reported in 
about 30 % of these lymphoma patients [146] and a 
further report found that about 13 % of the 
lymphoma patients which shared clinical symptoms 
with HLH carried monoallelic perforin mutations, and a further 13 % carried biallelic 
perforin mutations [147]. Another study found a strong (50 %) incidence of diverse 
types of malignancies with homozygous perforin mutations in carriers which had not 
Figure 2. A classic Reed-
Sternberg cell with two nuclei and 
enormous nucleoli. 
From:  Stanford Medicine, Dep. of 
Hematopathology.   
(http://hematopathology.stanford.
edu/) 
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developed FHL [148]. Thus, in mice and humans, subclinical heterozygous FHL 
variants could yield partly reduced immunosurveillance, marginally reduce control of 
infections, and / or allow for long-term subclinical chronic inflammatory processes 
which can build up over time to an enhanced risk for HLH and malignancy. 
 
Occasionally, PID patients can develop Hodgkin (HL) and Non-Hodgkin lymphomas 
(NHL) which are malignancies of the lymphocyte compartment, and several cell lines 
can be affected. In HL, B cells are often transformed. The diagnosis of HL and NHL 
is based on the histological identification of Reed-Sternberg cells (RSC, Figure 2). 
If RSC are present, it is classified as HL. RSC are transformed, often EBV-infected 
and enlarged B cells, which can contain several nuclei. They tend to bear mutations 
in their rearranged Immunoglobulin genes and can present with aberrant signaling 
[149, 150]. Their development or pathogenesis is not clear. RSC are CD15+ CD30+ 
CD45-. However, also a few peripheral T-cell neoplasms were found to have similar 
phenotypes [151]. If they are infected by EBV, the RSC can be stained for EBERs 
which are small viral RNAs that are produced and secreted in high amounts by the 
infected cells. These support transformation, hinder apoptosis and drive immune 
activation [152]. Another factor sometimes abundantly present in RSC is PAX5, a 
transcription factor which promotes B cell lineage specific genes and its positivity in 
RSC was correlated with worse clinical outcome [153, 154]. A staining that can be 
used to visualize the accumulation of histiocytes / macrophages is CD68, a 
lysosomal protein highly expressed in macrophages, although this is not a specific 
staining [155]. It is the combination of histological stainings which allows for 
unambiguous classification.  
 
One notion on development of HLH versus malignancies in individuals carrying FHL 
/ FHL-like genetic predispositions could depend on the extent of the phenotype of 
the genetic variation. Accordingly, the organism would either directly progress to full-
blown HLH once the trigger was set, if the mutation has full penetrance and / or 
severely compromises protein function. In the case of mild, heterozygous or lower 
penetrance variants, the body instead would succumb to lower, long-term chronic 
inflammatory processes which could eventually promote transformation. For the FHL 
/ HLH field, it is important to report and understand the connections between 
hyperinflammation and the rise of malignancies, so that prognoses and treatments 
can be chosen with best accuracy and can be adapted and refined according to the 
patient. 
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1.4 THE MUNC18 – SYNTAXIN INTERACTION 
 
The list of genes associated with FHL imparts that absence of non-redundant 
cytotoxic granule exocytosis proteins can rapidly evoke a life-threatening 
inflammatory state upon an infectious trigger. Syntaxin-11, Munc18-2 and Munc13-4 
have all been identified as key mediators of exocytosis in cytotoxic lymphocytes. In 
general, the Munc18 / syntaxin interaction is central to vesicle exocytosis. However, 
we are only beginning to understand the molecular details about the Munc18-2 / 
syntaxin-11 interaction and their implications for protein stability, localization and 
function. 
 
 
1.4.1 Munc18-1 and -2 
Genetic variations in genes encoding Munc18 proteins, as well as syntaxins, have 
meanwhile been implicated in various diseases, for example obesity and diabetes 
[156, 157], immunological phenotypes (FHL, see Table), or neurological 
abnormalities such as epilepsy, anxiety-like behavior or changes in long-term 
potentiation and depression of neuronal circuits [158-162]. Munc18-1 (the 
corresponding neuronal syntaxin is syntaxin-1) is the major neuronal SM protein 
involved in neurotransmission as Munc18-1 null mice are entirely deficient in 
neurotransmission and suffer from substantial neurodegeneration [163]. 
Heterozygous mutations in Munc18-1 have, amongst others, been linked to 
development of (early infantile) epileptic encephalopathy (also known as Ohtahara 
syndrome) [164-168]. Munc18-2 is encoded by the gene STXBP2 and has been 
associated with the development of FHL5, which dramatically affects the function of 
cytotoxic lymphocytes [23, 169].  Interestingly, both NK cells and CTL equally rely on 
the key components Munc18-2, syntaxin-11 and the hematological priming factor 
Munc13-4 in a comparable fashion, as cytotoxicity in patients lacking any of them 
was similarly impaired in both cell types [33]. Of note, FHL has mostly been 
considered to be an autosomal recessive disease, however, one heterozygous 
Munc18-2 mutation was reported to act in a dominant-negative fashion [170]. 
Munc18-2, like syntaxin-11, is broadly expressed throughout the immune system 
(additionally to some other cell types); and it has been implicated in exocytosis 
events in different immune cells, and also some non-immunological cells. For 
example, Munc18-2 was important in platelet secretion more so than other Munc18 
proteins, although they express Munc18-1, -2 and -3 [171]. Munc18-2 also plays an 
important role in mast cell degranulation, supposedly together with syntaxin-3, but 
not -4 [172, 173]. Munc18-2 and -3 together with syntaxin-3 and -4 were shown to 
mediate exocytosis events in neutrophils [174]. Besides the immune system, 
Munc18-2 has also been shown to play roles in insulin secretion, where it likely acts 
in concert with other Munc18 proteins, such as Munc18-1 and -3, to regulate 
exocytosis [175-177]. In cytotoxic lymphocytes, Munc18-2 is mostly found on 
intracellular vesicular structures (Figure 3) and assumedly, similarly to syntaxin-11 
(maybe even guiding syntaxin-11 trafficking), is recruited to the immunological 
synapse upon conjugate formation with target cells.  
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Figure 3. Syntaxin-11 or Munc18-2 do not pronouncedly overlap with cytotoxic granules, or 
the plasma membrane (indicated by perforin and 2microglobulin staining, respectively). NK 
cells from a healthy donor were seeded on poly-l-lysine-coated glass surfaces, fixed and 
stained for syntaxin-11 together with perforin (a) or 2microglobulin (b), or stained for Munc18-
2 together with perforin (c) or 2microglobulin (d). The first image of each row depicts the 
overlay of DAPI stain (gray), syntaxin-11 or Munc18-2 (raspberry), and perforin or b2m (yellow), 
respectively. Size bar 10 m. Stx11. Syntaxin-11; Prf, perforin; b2m, 2-microglobulin. 
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1.4.2 Binding modes 
There is not much known about the details of the interaction between syntaxin-11 
and Munc18-2. In fact, most knowledge about Munc18 / syntaxin interactions is 
derived from the neuronal counterparts, Munc18-1 and syntaxin-1. Some data 
suggest that Munc18 proteins can only bind the tightly packed, closed syntaxin 
conformation, having no effect on or even preventing it from forming SNARE 
complexes [178-182], and spatial segregation of SNARE complexes versus Munc18-
syntaxin complexes had been reported in a mast cell line, analyzing Munc18-2 and 
syntaxin-3 [183]. However, there is data indicating that Munc18 could bind syntaxin 
also when the syntaxin is in a SNARE complex [184-186], and Munc18-bound 
syntaxin can readily undergo SNARE complex formation upon encounter of 
membrane-bound VAMP2. It was thus suggested that the Munc18-syntaxin 
interaction could possibly persists over the different binding stages of the SNARE 
cycle, and hence convey a sequence of differential interactions between the two 
proteins [187-189].  Such a complicated dynamic interaction is possible because of 
several interaction surfaces, on both proteins. First, the syntaxin-1 N peptide 
(comprising two or three very N terminal charged residues followed by hydrophobic L 
(Leu) or F (Phe) residues, often indicated as the first 20 amino acids [190-192] can 
bind to a hydrophobic pocket on Munc18-1 formed by several residues, for example 
F115 and E132 [193]. Second, the large internal groove of Munc18-1, formed by 
domains -1 and -3a, can bind to another syntaxin-1 domain residing further 
downstream in the N terminus: This syntaxin domain consists of three helical parts 
which together form the Habc domain. (Figure 4). These two types of interaction 
are not necessarily mutually exclusive and they could fulfill different functions.  
 
 
Figure 4. Structure of Munc18-1, syntaxin-1 and the binary complex. (a) The binary complex is of 
Munc18-1 (in shades of blue) and syntaxin-1 (in red, orange and yellow, according to the domains). (b) 
Syntaxin-1 in the closed conformation folds as a partly helical bundle, with the SNARE domain partially 
wrapped around the Ha, Hb and Hc helices. The linker domain (red) is partly unstructured and partly 
helical. (c) Munc18-1 consists of 4 bulky domains (1, 2, 3 a and 3b) which form a large internal groove that 
can bind to the folded Habc/SNARE domain bundle of the syntaxin, as shown in (a). The hydrophobic 
pocket resides in the outwards-facing surface of Munc18 domain 1 (not highlighted for clarity). From [13]. 
 
 
It was found that the Munc18-1 domain-1 is essential for syntaxin binding and 
mutations in that region confer aberrancies in vesicle priming because the Munc18-1 
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chaperoning function is impaired [194]. In line with this, it was seen that L46 (Leu46) 
and E59 (Glu59) in domain 1 (of Munc18-1 and -2) are important for the interaction 
with syntaxin-3, thereby mediating its chaperoning [195]. On the other hand, 
mutations in the Munc18 domain-3 abrogated exocytosis but they did not interfere 
with vesicle docking or syntaxin-1 localizing to the plasma membrane. This domain 
may thus serve a distinct or additional function to chaperoning, being implicated in 
syntaxin-1 stabilization and vesicle priming for fusion [196]. More detailed, some 
point mutations in the domain-3a suggested that this part has a role in granule 
exocytosis but less so in syntaxin localization, with a particular emphasis on amino 
acid P335 being key for chaperoning syntaxin-1 [197, 198]. Another study added that 
a stretch in the Munc18-1 domain-3a also provides the interaction surface for 
VAMP2 [199]. 
 
The interaction between the N peptide of syntaxin-1 and Munc18-1 was found to be 
conserved among several SM protein/syntaxin pairs, for example in the syntaxin4-
Munc18-3, or syntaxin3-Munc18-2 interactions [200], but it is not clear how many of 
the syntaxin-SM protein interactions are characterized by both binding modes [201]. 
Despite considerable controversy in the field, many researchers appreciate that the 
interaction with the N peptide is not an optional binding possibility [202]. Hydrophobic 
pocket mutants on Munc18-1 or Munc18-2 both showed impaired interaction with 
syntaxin-11 [193], suggesting that syntaxin-11 might depend on its N peptide for 
proper Munc18 interaction. In C. elegans, lack of SM protein interaction (due to a 
mutation in the hydrophobic pocket) with the corresponding syntaxin homologue N 
peptide abrogated syntaxin binding, affected exocytosis and produced a classical 
uncoordinated (UNC) phenotype [203] with loss of locomotion in these worms [204]. 
Interestingly, in this study, a constitutively open syntaxin mutation (“LE mutation”, 
syntaxin-1 p.LE165,166AA) [178] did not produce an UNC phenotype and was thus 
assumed not to play much of a role in exocytosis in C. elegans. Another study 
however [205] showed that syntaxin N peptide point mutations (L8A or D3R) did also 
impair binding to Munc18-1 but rescued secretion in syntaxin-1 deficient PC12 cells 
(a neuroendocrine cell line). On the other hand, the combination of these point 
mutants + LE mutation could not. In line with the previous study, in this study, the LE 
mutation alone rescued secretion well, too, despite considerable protein 
mislocalization. The N peptide was thus suggested to play an important role in 
interaction with Munc18-1 and trafficking of syntaxin-1 but it might be less important 
for exocytosis. Genetically modified worms subjected to the N peptide point mutants 
+ LE mutation produced egg-laying defects, slower locomotion and slower growth 
rates. In Munc18-1 and -2 double knockdown neurosecretory cells, it was found that 
a mutant of Munc18-1 that cannot bind to the closed conformation of syntaxin-1 
could not rescue syntaxin-1 expression, localization or secretion. This was in 
contrast to mutations which abolish N peptide binding. These could rescue the 
phenotype [206]. Thus, it was concluded that, in this system, the N peptide 
interaction was not essential for exocytosis. Another study showed that the minimal 
complement a syntaxin protein has to possess in order to mediate fusion (in an in 
vitro liposome fusion assay) is the N peptide and the SNARE domain; all other 
features might thus possibly have other roles for syntaxin. The authors suggested 
that the big groove found in Munc18-1 can in these complexes likely be occupied by 
the heterotrimeric SNARE four-helix bundle instead of the monomeric Habc-SNARE 
bundle provided by the syntaxin alone, and it may be plausible that these bundles 
might compete for the Munc18 groove also in a physiological setting [207]. Some 
authors suggested that the N peptide could compete with the closed syntaxin 
homologue conformation for binding to the Munc18 homologue protein [208]. These 
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and other studies could hint towards a scenario of interaction mode hierarchies, or 
sequential regulation of binding modes. For syntaxin-4, in one study the N peptide 
was found negligible for its targeting, but important for its stabilization at the 
basolateral membrane in epithelial cells and this was dependent on the interaction 
with Munc18-3 [209]. However, an in vitro study on Muc18-3 and syntaxin-4 found 
the N peptide was needed for binding, whilst for syntaxin-1 / Munc18-3 the N peptide 
was not necessary [210]. Thus, syntaxin-4 and syntaxin-1 could employ different 
modes of binding, with syntaxin-1 found in closed and open conformation (the N 
peptide would promote the open conformation), whereas syntaxin-4 would be mostly 
or only found in open conformation when bound to Munc18-3. Another study [211] 
interestingly found that Munc18-1 and -3 could also recognize different parts of 
VAMP proteins, here shown for VAMP2. One study showed that the N peptide can 
have a role in recruitment of SM proteins to the syntaxin [190]. The authors saw that 
the N peptide recruited the SM protein, also if it was fused to other SNARE proteins, 
or if the spacing between the SNARE domain of syntaxin-1 and the N peptide was 
changed. Surprisingly, when cleaving off the N peptide after the binary complex is 
formed, it did not manipulate fusion any more, hence once the complex is formed, 
the N peptide could be negligible for fusion. In total, they concluded that the N 
peptide functions as initiator for the SNARE-SM membrane complex. That can be 
true, however, in vivo, this initial recruitment of the SM protein to the syntaxin likely 
has to occur upstream of the plasma membrane stage of syntaxin-1 (see chapter 
1.4.3). How or if syntaxin-11 and Munc18-2 interaction is dependent on a functional 
N peptide is not known. Also, the mechanism of how syntaxin-11 Habc domain 
mutations can cause disease is not well understood, because very little is known 
about the exact interaction modes of this specific SM / syntaxin pair. 
 
 
1.4.3 Trafficking of syntaxins: dependence on Munc18 
In Munc18-1 deficient chromaffin cells, vesicle docking was abolished and syntaxin-1 
levels were decreased [14, 16]. Interestingly, docking could be compensated for 
when expressing Munc18-2 instead, but the vesicle priming steps were then partially 
aberrant. Also, in this model, syntaxin-1 trafficking to the plasma membrane was 
dependent on co-expression of Munc18-1 or -2 [16]. Along those lines, Munc18-1 
was also required to target syntaxin-1 to the plasma membrane in PC12 cells, but 
not for SNAP25 targeting [212]. The stimulatory function despite binding to the 
closed syntaxin conformation is in line with previously contradictory observations 
showing that Munc18 prevents SNARE complex assembly if incubated with 
compatible SNARE-vesicle populations before mixing the vesicle populations [10]. 
The binding to the closed conformation could thus stabilize the syntaxin when it is 
not implicated in membrane fusion, for example while it is trafficked to its terminal 
subcellular compartment. Throughout its trafficking the syntaxin mustn’t undergo 
SNARE complex formation. In one study in which it was permitted so, syntaxin-1 did 
not reach the plasma membrane, and neither did SNAP25. The interaction syntaxin-
1-Munc18 thus probably has to occur before it meets SNAP25 on the Golgi complex. 
The initial interaction was found to be dominated by Munc18 binding to the Habc 
domain of syntaxin, rather than the N peptide [213]. Regarding stability of syntaxin, 
also studies on baker´s yeast showed that the SM protein Vps45 was important to 
stabilize the syntaxin homologue Tlg2p as this was rapidly degraded by the 
proteasome when Vps45 was absent [214, 215]. Trafficking of syntaxin-1a was also 
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found to be dependent on co-expression of Munc18-1 in polarized epithelial cell 
lines. In this system, Munc18-2 could equally well traffic syntaxin-1a to the surface 
[216]. It is likely that syntaxin-11 depends on Munc18-2 for its trafficking but that has 
not been addressed in detail yet. 
 
1.4.3.1 Concluding notes on Munc18 
It should be noted that not all functions of Munc18-1 are in one way or another 
connected to syntaxin-1 interaction. Analysis of a series of mutations from Munc18-1 
homologues from different model organisms showed that some mutations clearly 
produced a phenotype but they did not affect the syntaxin-1 interaction. Thus, it 
became clear that also other protein interactions could be important for Munc18-1 
function [217]. It was concluded that Munc18-1 controls various stages of exocytosis, 
including syntaxin-independent steps. One study found that Munc18-1 must exhibit 
an essential mechanism for survival of neuronal cells. Munc18-1 mutant mice grew 
normal neuronal networks which formed synapses, but these degenerated over time. 
In vitro, neuron survival was prolonged for some days when adding external trophic 
factors but the degeneration occurred inevitably [218]. Long-term survival of neurons 
is thus not directly coupled to exocytotic activity, but to expression of Munc18-1. 
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1.5 MUNC13 AS POSSIBLE MODIFIER OF THE SYNTAXIN – 
MUNC18 COMPLEX 
Munc13 proteins mediate a step immediately upstream of fusion, termed vesicle 
priming. Munc13 deficiency can still allow for vesicle docking to the plasma 
membrane but fusion is impaired. [219-221]. Munc13-1 and -2 deficient neurons can 
still form morphologically normal synapses [222]. An important insight came from a 
C. elegans study showing that a constitutively open form of syntaxin abolished the 
necessity of UNC13 in the priming of synaptic vesicles [223], which pointed towards 
a role of Munc13 proteins in supporting the opening of the syntaxin to render it 
capable of mediating fusion. This is in line with another report referring to another 
protein implicated in vesicle priming, CAPS1, which was found to bind well to “open” 
syntaxin whereas Munc13-1 was preferentially found to bind to the N terminal 80 
amino acids of syntaxin-1, rather than the entire recombinant protein (without 
transmembrane domain) [224]. In line with the potential impacts on syntaxin 
conformation, Munc13 and Munc18 have both been shown to interfere with the 
SNAP25-syntaxin-1 binding stoichiometry. Addition of both promoted a binary 1:1 
complex, as opposed to an aberrant 1:2 (SNAP25:syntaxin) stoichiometry; and this 
binary complex supports syntaxin-1 shifting towards an open, more accessible 
conformation [225, 226]. In summary, Munc13 could accelerate the transition of the 
binary syntaxin-Munc18 complex to the SNARE complex. Some authors mapped 
this function to a particular domain, the Munc13 MUN domain (Munc13-1 amino 
acids 859–1531, [227], which directly interacts with the syntaxin-1 SNARE domain. 
Similarly, Munc13-4 has been shown to interact with syntaxin-1, -4 and -11 SNARE 
domains. Physically, the Munc13-syntaxin interaction appeared not to be a very 
strong interaction, but it seems to be sufficient to fulfil this essential role in exocytosis 
[228-232]. What role this interaction plays during exocytosis is not certain, but a 
delicate scenario can be envisioned incorporating several findings. For example, the 
big Munc18 binding groove (between domains 1 and 3a), initially binding the 
syntaxin Habc and SNARE domain, could compete with the weak Munc13 
interaction for the SNARE domain and eventually the Munc18 could allow the 
Munc13 to dissolve the SNARE domain from the folded Habc / SNARE bundle, 
allowing for subsequent SNARE complex formation. The big Munc18 groove could 
then possibly bind the terminal SNARE complex [207] instead of the syntaxin Habc 
domain, even if these interactions may not rely on exactly the same surfaces [233]. 
Throughout these steps, the N peptide of the syntaxin could continuously be bound 
to the hydrophobic pocket of the Munc18 protein, ensuring that the chaperone stays 
associated to the syntaxin, even if it may be negligible for fusion after the initial 
interaction [190]. Munc13 might thus promote the open syntaxin conformation and 
interfere with a re-closing of the syntaxin until it can form a SNARE complex with 
other SNARE proteins. 
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1.6 SYNTAXIN-11 
 
Syntaxin-11 is encoded by the gene STX11. The syntaxin-11 amino acid sequence 
displays considerable homology to syntaxin-1, hence the basic protein architecture is 
probably similar. Syntaxin-1 comprises several functionally important domains. 
These are the N peptide, the Habc domain, a linker domain (not known to assume a 
particular secondary structure), a SNARE domain, and a membrane anchor domain, 
which in the case of syntaxin-1 is a transmembrane domain. Syntaxin-11 does not 
have a transmembrane domain, but it can get palmytoylated and this confers its 
membrane anchorage [234-237]. Syntaxin-11 in fact is tightly bound to membranes 
as it was not resolved from membrane fractions with high salt or high pH, and only 
partially (approximately 70-90% of total) with Triton-X-100. Recombinant syntaxin-11 
can bind to VAMP2 and SNAP23, but not syntaxin-2 [234, 235]. In human platelets, 
that syntaxin-11 – SNAP23 interaction was confirmed, and it also bound to VAMP8 
and VAMP3, but not syntaxin-4 [238]. Also, it was shown to interact with Vti1b, 
another SNARE protein implicated in intracellular fusion processes such as 
endosome – lysosome fusion [239]. 
 
Syntaxin-11 was first described and characterized around 1998. Syntaxin-11 mRNA 
was most abundant in human lung, placenta and heart, somewhat less in liver, 
pancreas, kidney and skeletal muscle, and almost absent in brain tissue lysate [240]. 
This tissue distribution was also seen in another syntaxin-11 study on mRNA and 
protein level [234]. Within immune populations evaluated to date, syntaxin-11 was 
observed  in cytotoxic lymphocytes [32, 236], monocytes and macrophages [22, 239, 
241], neutrophils [242], platelets [238], and B lymphoyctes [234]. Deficiency in 
syntaxin-11 has been associated with degranulation defects in the cytotoxic 
lymphocytes and development of FHL4 [22, 32, 243]. Of note, a few exceptional 
FHL4 patients were recorded with the ability to degranulate, albeit to a lesser extent 
than controls [244]. In healthy cells, cytotoxicity was suggested to correlate with 
syntaxin-11 expression levels, and that is for example mirrored in the functional 
maturation of CTL, which is accompanied by cell activation and this in turn has been 
shown to upregulate syntaxin-11 levels in human CTL [236, 245]. Syntaxin-11 (and 
Munc18-2) is part of the membrane fusion complex in cytotoxic lymphocytes [245]. In 
line with that, FHL4 (and FHL5) patient lymphocytes form normal conjugates with 
target cells and cytotoxic granule polarization towards the immunological synapse is 
morphologically normal [23, 32, 245]. FHL4 patient cells have been shown to 
partially gain back cytotoxicity upon IL-2 stimulation [32]. Presumably, most FHL4 
patients are absolutely deficient of syntaxin-11 expression and / or function. 
However, theoretically, in individuals who might harbor milder mutations which 
preserve residual protein functionality, the IL-2 induced gain in function (also seen in 
healthy cells, Figure 5) could be supported by syntaxin-11 levels being 
upregulated upon thorough pro-inflammatory cytokine stimulation ([241, 246] and 
Figure 6).  
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Figure 5. (Healthy) NK cell degranulation in response to K562 cells (K) after different pre-incubation 
times (schematically indicated by grey triangle) with various pro-inflammatory cytokines (color code). As 
control, a mouse cell line which does not induce NK cell degranulation by itself is shown (P815 cells, P). 
Whole PBMC were isolated from 3 healthy donors and pre-incubated with the cytokines for 8 different 
time points (0, 2, 4, 6, 8, 12, 16 or 24 h, respectively). Within the last two hours of the time course, the 
PBMC were mixed with either P815 or K562 cells and co-incubated for 2 h. The degranulation (CD107a 
exposure on the NK cell surface) assay was hence performed within the final 2 h of the time course. Each 
group of P815- or K562-stimulated PBMC shows one bar per time point, averaged over the three donors. 
Error bars indicate SD. 
 
In general though, and this is not well understood, syntaxin-11 deficient cells are 
readily recovering their function upon pro-inflammatory cytokine treatment, much 
more so as compared to other FHL patient cells. It was suggested that this could 
contribute to the fact that FHL4 patients present with a later age of onset and 
sometimes a milder disease course (see chapter 1.3.1) [138, 243]. A number of 
syntaxin-11 variants and mutations have been found meanwhile, spread over the 
entire protein sequence. One interesting mutation is for example syntaxin-11 
p.Q268X, which is truncated immediately downstream of the SNARE domain (see 
Figure 8 and [22, 243]). This mutation is very useful to determine trafficking steps 
of syntaxin-11 and analyze protein-protein interactions, as it is linked to a profound 
degranulation defect, but the interactions of the syntaxin N terminal domains could 
be undisturbed.  
 
A syntaxin-11 knockout mouse model provided data that loss of syntaxin-11 did not 
lead to developmental defects in immune cell populations, and similarly, our group 
has not observed any FHL4 patients with apparent immune system development 
abnormalities ([246] and unpublished obs). No impairment of macrophage or 
dendritic cell phagocytosis or cytokine secretion was observed. Mast cell 
degranulation was also not perturbed. However, an exocytosis defect was seen in 
these mice in the cytotoxic lymphocytes as well as in neutrophils, consistent with 
what is known from syntaxin-11 expression patterns and FHL4 patients.  
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Figure 6. Western blot and corresponding densiometry on healthy PBMC and NK cells from 2 
representative donors (black or raspberry, respectively). As indicated, some of the cells had been 
stimulated with 500 IU/ml IL-2 for 48 h. For comparison, a whole tissue lysate of a normal mouse brain 
was loaded, which does not express syntaxin-11. For densiometric analysis, protein levels were 
normalized to actin. D1, donor 1; D2, donor2. 
 
Syntaxin-11 is also mediating degranulation in platelets [238]. However, in some 
immune cells syntaxin-11 can have different purposes. In human monocytes, it was 
reported that syntaxin-11 expression negatively correlates with phagocytic activity 
and TNF secretion [241]. This could be relevant for the HLH context, and also add to 
the observation that FHL4 patients can persist without developing the disease for a 
longer time than other FHL patients, as they might possibly clear necrotic debris in 
infiltrated tissues better than other FHL patients. Remarkably, in macrophages, 
syntaxin-11 was reported to regulate endosome-lysosome fusion events via 
sequestering Vti1b away from forming SNARE complexes with other syntaxins, such 
as syntaxin-6 and -7, or -7 and -8. This sequestration prevented accumulation of 
large endocytic compartments and lysosome tubulation in healthy cells. In syntaxin-
11 knockdown cells, the late endosome-lysosome fusion (maybe also fission) was 
abnormal whilst trafficking and exocytosis of lysosomes was increased [239]. If 
syntaxin-11 possesses additional roles besides cytotoxic granule fusion in cytotoxic 
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lymphocytes is not known. The more we can learn about the syntaxin-11 interactome 
and the molecular details of these protein-protein interactions the better we can 
understand how syntaxin-11 acts, how it is regulated by its physiological 
environment, and how certain mutations but not others do impair particular aspects 
of its biology.  
 
 
1.6.1 About syntaxin-11 localization 
When overexpressed in NRK cells (a rat kidney cell line) the protein localized in a 
juxtanuclear region, and, surprisingly, when the C terminus downstream of the 
predicted SNARE domain was abolished, the protein still localized comparable to the 
wt. However, disposal of C terminus + SNARE domain caused a random 
cytoplasmic localization [235]. Another study using overexpression in HeLa cells 
found it to localize similarly as the cation-independent mannose-6-phosphate 
receptor (M6PR), and thus syntaxin-11 was ascribed to reside on the trans-Golgi 
network and late endosomes [234]. However, in activated human monocytes, 
syntaxin-11 was not found to associate with Golgi structures. Upon phagocytic 
activity, syntaxin-11 was seen at the plasma membrane [241]. How exactly it 
localizes in freshly isolated human cytotoxic lymphocytes, is not completely 
understood, but in intracellular stainings on endogenous proteins in non-conjugated 
cells, we have not observed it in the plasma membrane, and this is in line with 
observations on transfected NKL cells (an NK cell line) (see [247] and Figure 3). 
Similarly, in activated NK cell clones, the protein was reported on intracellular 
vesicular structures [236]. Besides, we have also not seen it pronouncedly co-
localizing with cytotoxic granules (Figure 3), which was suggested in an 
overexpression system in human CTL [245]. However, these data could rather 
indicate exocytic protein cluster formation right under the arriving cytotoxic granule 
(see [4]), as it was imaged in TIRF microscopy in transfected CTL, employing 
stimulatory (anti-CD3 / -28) coated glass surfaces. The same article suggested that 
syntaxin-11 is mostly found on Rab11a+ recycling endosomes in such 
overexpressed CTL, and when a synapse with a target cell is formed, it is recruited 
to the synapse prior to cytotoxic granules [245]. This is a reasonable assumption, as 
a lymphocyte does not “know” where it will form the next synapse, and thus would 
instead deliver the necessary components on demand. In resting human neutrophils, 
syntaxin-11 distributed over plasma membrane, tertiary, secondary and azurophilic 
granule fractions. However, when the cells were activated with PMA, they 
degranulated and syntaxin-11 shifted more towards the plasma  membrane and 
partially remained on azurophilic granules, whereas it left secondary and tertiary 
granules [242].  In macrophages, syntaxin-11 was found on endosomal and 
lysosomal membranes and a small fraction associated with the plasma membrane 
[239]. Insights into the trafficking of syntaxin-11 on subcellular compartments, if and 
how it is dependent on interactions with Munc18-2, and which fusion machinery 
targets syntaxin-11 to the plasma membrane on demand will provide important 
information about syntaxin-11 biology in cytotoxic lymphocytes, give clues on 
potential disease-causing mechanisms, possibly identify novel interaction candidates 
and maybe elucidate if the protein does fulfil other functions in these cells besides 
cytotoxic granule exocytosis.  
 
 
 29 
 
1.7 VAMPS 
To date, it is not clear which member of the VAMP family mediates fusion of the 
cytotoxic granules with the plasma membrane, and thus serves as the R-SNARE in 
fusion complexes. Several VAMPs were and are discussed as candidates; for 
example VAMP2, VAMP3, VAMP4, VAMP7 and VAMP8. VAMP2 was a strong R-
SNARE candidate after a report on mouse CTL showed that it localized on cytotoxic 
granules and ablation or inhibition of VAMP2 abrogated degranulation [248]. In these 
cells, VAMP3, -4 and -7 did not co-localize with granzyme B and thus may serve 
other purposes in mouse CTL.  However, VAMP2 protein was not detectable in 
human cytotoxic lymphocytes in our experiments (unpublished obs.). Similarly, a 
study on human platelets found no expression of VAMP1 or -2. Instead, VAMP3 and 
-8 were expressed, co-immunoprecipitated with syntaxin-4 and SNAP23, and both 
were required for granule secretion [249]. VAMP3 and Rab11a have also been 
implicated in cytokine release in an NK cell line (NK92). Of note, there was a 
reduction in perforin release upon inhibition of RE trafficking, but that was not 
significant [250]. Other authors found VAMP3, -4, -5 and -8 proteins expressed in 
human CTL, with VAMP4 and -8 showing a (partial) immunological synapse 
localization [251]. VAMP7 was found on the mRNA level, but no staining was shown. 
In an NK cell line (YTS), VAMP4 and -7 were both observed to be important for 
cytotoxic granule exocytosis, and interestingly, VAMP7 was also implicated in 
cytokine release. Moreover, VAMP7 was also found in areas partly overlapping with 
cytotoxic granules in non-conjugated cells, whilst VAMP4 was only found to overlap 
with perforin when the cells were in conjugates. VAMP7 might thus serve in several 
transport processes in cytotoxic lymphocytes, and VAMP4 may support a transport 
step specifically triggered upon and required for cytotoxic granule release. However, 
there was no evidence that particularly the cytotoxic granule-to–plasma membrane 
fusion is perturbed in these cells lacking either of these VAMPs, as the reduction in 
degranulation could in theory stem from other fusion processes for example 
preceding cytotoxic granule exocytosis [252]. VAMP4 has been implicated in 
intracellular transport processes, mostly trans-Golgi network to endosome transport, 
and it was additionally found on clathrin-coated and uncoated vesicles, endosomes 
and immature secretory granules in PC12 cells [253]. Also, VAMP7 was suggested 
to play a role in transport of triacylglycerol between ER and Golgi apparatus in 
intestinal endothelial cells [254].  
 
Some of the VAMP proteins may thus serve several functions in the same cell. The 
exact roles of VAMP3, -4, -7 and -8 in human cytotoxic lymphocytes deserve 
revisiting, as it is still not completely understood what function each of them has, or if 
they are partly redundant. All of them were found to be expressed in a rat mast cell 
line (RBL cells), and VAMP8 was suggested to form a complex with syntaxin-4 and 
SNAP23 to mediate exocytosis of secretory granules (lysosome-related) [255]. 
VAMP8 was found to form a complex with syntaxin-11 and SNAP23 in platelets 
[238], and moreover, in mice, VAMP8 was co-localizing with cytotoxic granules, 
found to be important for their exocytosis and target cell killing, and on top of that 
also cytokine release in CTL [256, 257]. Cytotoxic granule and MTOC polarization in 
conjugates were normal in VAMP8 KO CTL, implicating that upstream granule 
maturation and recruitment steps were not affected. These findings raised the 
question whether VAMP8 is expressed in human CTL, where it localizes and 
whether it could function in cytotoxic granule exocytosis directly, for example as the 
R-SNARE in the fusion complex.  
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2 AIMS OF THE THESIS 
This project focuses on gaining mechanistic insights on how variants and mutations 
in FHL genes can interfere with exocytosis, abrogate cytotoxicity and cause disease. 
In the known FHL genes, mutations have been found all over the sequences and 
also, the genetic states of FHL patients are highly variable. Thus, protein properties 
can be affected to a variable degree, which translate into altered protein interactions, 
localization, stability or other parameters determining efficiency of exocytosis. 
Besides the mechanistic understanding on how FHL variant proteins can lead to 
aberrant exocytosis, there is still a lack of knowledge about the wt proteins, 
regarding for example their trafficking. Thus, we also aimed at characterizing the 
trafficking of wt exocytosis-associated SNARE proteins VAMP8 and syntaxin-11. 
 
 
 
Paper I 
 
 Follow-up on a particular FHL5 patient case (Munc18-2 p.Q432X and p.S545L) 
 Evaluate Munc18-2 protein levels in patient PBMC 
 Histopathology to clarify diagnosis of classical Hodgkin lymphoma  
 Characterize functionality of tumor-infiltrating and peripheral lymphocytes 
 
 
Paper II 
 
 Evaluate cytotoxicity and cytotoxic granule integrity of FHL4 patients  
 Understand how N-terminal mutations in syntaxin-11 can impact protein 
expression and interaction with Munc18-2  
 Explain how an N-terminal mutation in syntaxin-11 can cause disease (syntaxin-
11 p.L58P) 
 
 
Paper III 
 
 Understand the role of VAMP8 in cytotoxic granule exocytosis 
 Gain insigth into the trafficking route of VAMP8 
 Study if there is a relationship between VAMP8 trafficking and synatxin-11 
trafficking 
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3 RESULTS AND DISCUSSION 
3.1 PAPER I 
The study contains clinical and functional follow-up data on an FHL5 patient, who 
had previously suffered from active HLH, and had at the time been reported with the 
clinical parameters [129]. That HLH flare had initiated with prolonged fever, 
abdominal pain and sore throat. The patient reported decreased ability to breathe 
and adenoids as well as tonsils were removed or abraded. This however yielded 
severe bleeding which was accompanied by reduced platelets. The patient was thus 
given platelet infusions, coagulation factors, fibrinogen concentrate and, due to 
hypogammaglobulinemia, intravenous immunoglobulin (IVIG). The patient 
subsequently progressed towards renal failure, and had to undergo renal 
replacement therapy. Besides, the patient was tested EBV+. Heterophile antibodies 
as well as a high EBV DNA copy numbers were detected. Hence, rituximab was 
administered which helped to improve the patient condition. There was no 
hemophagocytosis detected in a bone marrow aspirate of the patient. When the 
authors tested for NK cell function, they found a profound degranulation and target 
cell killing defect. However, the patient partially regained function after 3 days of IL-2 
incubation. As the lack of NK cell function had been the final criterion for being 
diagnosed with HLH, treatment according to the HLH-94 guidelines was started 
[258]. The patient received etoposide (a chemotherapeutic drug) and 
betamethasone (a corticosteroid). The therapy stabilized the patient substantially, 
and the protocol was reduced to administering corticosteroids and IVIG, as antibody 
titers remained low. However, the patient kept suffering from recurrent flares of 
abdominal pain, vomiting and diarrhea. Another virus infection was detected 
(Calicivirus) which however cleared rapidly. The patient had also developed a colitis 
which could be successfully treated. The hypogammaglobulinemia persisted though, 
and thus IVIG was administered throughout the following symptom-free time. About 
two years later, the patient presented to the clinics again, and we wanted to follow up 
on this particular case [259]. This time the patient presented with a fast-growing 
lateral swelling on one side of the neck (Paper I, figure 2). A localized 
lymphadenopathy was found and the affected lymph nodes were removed. When 
analyzing that tissue, the markers EBER and PAX5 were detected, reconfirming the 
presence of EBV. The tissue was also tested regarding the possibility that the 
swelling was induced by a rapidly progressing lymphoma. The hematoxylin-eosin 
staining revealed a high lymphocyte infiltrate and some cells morphologically 
resembled Reed-Sternberg Cells (RSC, see also Figure 2). Further analysis 
confirmed this, as these enlarged multinuclear cells stained positively for PAX5, 
CD30 and CD15, which indicate EBV+ RSC. Specific stainings for CD3, CD8, 
perforin, granzyme B and CD68 confirmed high numbers of infiltrating cytotoxic T 
cells and macrophages. These findings supported the diagnosis of classical Hodgkin 
lymphoma.  
 
Because of this second clinical episode, we decided to look at the protein expression 
of Munc18-2, since it was not clear how stable Munc18-2 would be, as the patient 
carries a biallelic Munc18-2 mutation (p.Q432X and p.S545L, see [129], table 1). 
Therefore, a Western blot was performed on patient PBMC (Paper I, figure 1). 
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Protein levels were dramatically reduced, almost to the threshold of detection. 
Interestingly, this did not change when the PBMC had been incubated in high 
amounts of IL-2 overnight, which is sufficient to achieve partial recovery of 
cytotoxicity. The protein level of syntaxin-11 had not been assessed at the time. 
Syntaxin-11 and Munc18-2 interact with each other ([169], Paper II, figure 4e and 
Figure 7), and both proteins are important for cytotoxic granule exocytosis, 
similarly to the syntaxin-1 – Munc18-1 interaction determining neurotransmitter 
release.  
 
 
 
 
Figure 7. Co-immunoprecipitation experiment addressing the promiscuity of Munc18-2 – syntaxin 
interaction. HA-tagged syntaxin-1 to -4, all of which are closely related to syntaxin-11, were 
overexpressed in HEK293 cells. FLAG-tagged Munc18-2 was overexpressed in another batch of HEK293 
cells. The FLAG transfectants were lysed, and the IP was performed with a monoclonal -FLAG antibody. 
The bead-bound -FLAG IP was washed and equally distributed for the Co-IP reactions. Subsequently, 
the whole cell lysates of the syntaxin transfectants were added. The upper Western blots show the whole 
cell lysates, the Co-IP is shown in the lower panel. WCL, whole cell lysate; IP, immunoprecipitation; Untx, 
untransfected; EV, empty vector. 
 
It has been observed in numerous FHL5 patients that loss of Munc18-2 results in 
reduced levels of syntaxin-11 [23, 169, 171]. This is somehow reminiscent of 
Munc18-1 stabilizing syntaxin-1 [260]. It could be that FHL5 patients, who lose both 
proteins, suffer from the degranulation defect mostly because they lose syntaxin-11, 
which could be degraded due to the lack of protection from its chaperone. A 
constitutively open version of syntaxin-1 produced greatly reduced interaction with 
Munc18-1 and the syntaxin was more susceptible to trypsin-mediated cleavage 
[261]. However, this has not been addressed in molecular detail. Analysis of intrinsic 
FHL protein stability is complicated by the fact that for example variants of syntaxin-
11 which are dramatically destabilized in patient cells (see Paper II, figures 3, 4) 
can be perfectly transiently overexpressed in cell lines as well as primary cytotoxic 
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lymphocytes. Such overexpression systems might thus not mirror physiological 
conditions very well. An optimal system copying physiological conditions is currently 
not available. Ideally, such a test system would be based on 1) primary cells and 
expression levels, 2) inducible (to gain insights into expression kinetics and maybe 
turnover times, and compare physiological parameters before and after expression), 
and c) subcellularly traceable to simultaneously understand how they traffic, and if 
they ever reach the membrane upon conjugate formation with a target cell. The 
impact of Munc18-2 binding on syntaxin-11 stability has to be addressed in more 
detail in the future.  
 
 
 
Figure 8. HEK293 cells were co-transfected with HA- or FLAG-tagged Munc18-2, SNAP23, syntaxin-11 
wt or variant constructs, as indicated. The cells were lysed and corresponding protein amounts were 
loaded. The membrane was blotted for the tags, HA or FLAG, as well as actin. The corresponding 
densiometry is shown on the upper right. Protein levels were normalized to actin. In the lower right 
corner, a schematic syntaxin-11 overview is given, with the variant positions indicated. In raspberry, the 
N peptide is indicated, the purple stretch refers to the Habc domain, orange indicates the SNARE domain 
and green marks the palmytoylation sites for membrane anchorage.  The two mutations which are later 
on described in PAPER II are given with the amino acid exchange. Untreated: No lipofectamine. 
Untransfected: Cells had been treated with lipofectamine. EV, empty vector; var, variant. 
 
Also, an important side observation highlights that the interaction between syntaxin-
11 and Munc18-2 may not only impact stability unidirectional. Not only does 
Munc18-2 determine syntaxin-11 levels, but we saw that depending on the version of 
syntaxin-11 being co-expressed with wt Munc18-2 in a cell line, the levels of 
Munc18-2 can also vary greatly (Figure 8). In summary, we can currently interpret 
that the quality of interaction, which is to some extent determined by both proteins, 
could dictate protein stability, availability for SNARE complex formation and 
efficiency of exocytosis. The other protein assessed in the Western blot, Rab27a, is 
linked to a HLH-like disease, Griscelli syndrome type 2. Rab27a is not known to 
interact with syntaxin-11 or Munc18-2. But it plays a role in cytotoxic granule 
tethering and exocytosis at the immunological synapse; and for these functions it 
needs to interact for example with Munc13-4 or Slp2a, wherein Slp2a might impact 
Rab27a recruitment to cytotoxic granules and the immunological synapse [262-265]. 
Though this may not be surprising, it is helpful to confirm that interruption of the 
Munc18-2 - syntaxin-11 interaction and the subsequent lack of exocytic activity likely 
does not downregulate protein levels of other exocytosis-related genes [266].  
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An intriguing question is whether cytotoxic granule exocytosis is perceived by the cell 
and accordingly if granule or exocytotic protein availability is controlled and adjusted. 
This exciting question remains to be addressed in detail, but from the current and 
other FHL patients, we can at least deduce that biogenesis of cytotoxic granules 
cannot be coupled to FHL protein function or expression, which in turn of course 
determines exocytosis capability. Hence, even if the lymphocytes sense the lack in 
exocytic activity, one interesting difference to neurons is that lymphocytes apparently 
do not need Munc18-2 expression or exocytosis for long-term survival, as opposed 
to neuronal cells being dependent on Munc18-1 expression [218]. Of course, a 
decrease in degranulation and killing might also stem from a further possible 
complication which might influence other proteins (expression levels and / or 
distribution). That is, for example, if the syntaxin-11 / Munc18-2 interaction would 
have additional roles in intracellular fusion processes affecting organelle maturation 
or sorting of lysosomal cargo. We briefly looked into this question in Paper II, figure 
2, where we did not observe abnormalities in granule constituents upon syntaxin-11-
related degranulation deficiency [267].  
 
A new assessment of patient cell degranulation and cytotoxicity displayed similar 
results as in the first patient report. This time, not only K562 were used as targets, 
but also stimulation via monoclonal antibodies activating CD16, or CD3, respectively, 
in a redirected lysis assay (Paper I, figure 3 B-E). This is possible because P815 
cells are not killed by NK cells, but they express Fc receptors and can thus bind the 
monoclonal antibodies directed against lymphocyte activating receptors (CD16, and 
CD3), cluster them and induce degranulation and target killing. The patient cells 
gained cytotoxicity upon IL-2 pre-incubation, against K562 and following CD16 
stimulation. The same held true for cytotoxic T cells. This corroborated and widened 
the previous findings. It also shows that the compromised peripheral blood 
lymphocytes do not alter functionality on the long run, due to for example medical 
treatment or the state of inflammation in the surrounding tissues, as it has been 
postulated for some FHL patients [127].  
 
In general, a few FHL5 patients, but even more so, literally all FHL4 patients have 
been observed to partially gain back degranulation and killing ability after pro-
inflammatory cytokine incubation. The same effect has been well established in 
healthy cytotoxic lymphocytes, and can be achieved by several pro-inflammatory 
cytokines (Figure 5). Nevertheless, as the FHL patient records clearly show, per 
se, cytotoxic granule exocytosis is not redundant and cannot be compensated for 
during the initial phase, the trigger, of disease in vivo. Otherwise the patients should 
be able control the pathologic stimulus and a hyperinflammation would never be 
established. Actually, the non-redundancy comprises cytotoxic granule exocytosis as 
well as proper detachment from the target, as this was shown to play a key role in 
the high production of pro-inflammatory cytokines [133]. The pro-inflammatory 
cytokines at some point might reach sufficient local tissue concentrations to aid the 
lymphocytes to partially regain function, but at that point the hyperinflammation might 
already be independent of the initial trigger, where other mechanisms such as self-
maintaining inflammation with limiting IL-2 availability and shift of immune 
populations might dominate. Hence, in vivo, as opposed to the initial phase of the 
disease, once the HLH is fully ongoing, it may not matter anymore whether the 
lymphocytes gain some functionality back due to elevated cytokines (like, for 
example, the cells of the patient of this study possibly could, in highly inflamed 
tissues), and eventually could even limit the initial infectious trigger.  
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From a cell biological point of view, the observed cytokine effect is a very interesting 
phenomenon, because it highlights a) adjustability of the process, and b) the 
elevation of lymphocyte function must be independent of the respective FHL protein. 
Regarding this compensatory capability, it should be noted that there is a grading 
over different FHL genes, with syntaxin-11 being most easily compensated for, but 
also for a number of FHL5 patients this has been observed [32, 129]. The ease of 
such compensation in FHL4 cells as opposed to other FHL genes could also explain 
why FHL4 patients develop the hyperinflammation later than other FHL patients [32]. 
One group suggested that the compensation in FHL4 and FHL5 may be ascribed to 
upregulation of other syntaxins, or other Munc18 proteins, respectively. This has 
been observed in lymphocytes stimulated with high doses of cytokines for several 
days [268], and we and others have observed that Munc18-2 can indeed interact 
with several syntaxins closely related to syntaxin-11 (Figure 7). Moreover, a study 
on Munc18-1 and -2 double knockdown neurosecretory cells showed that loss of 
both Munc18 proteins affected a range of syntaxins, as syntaxins-1a, b, -2 and -3 
were all found to be reduced significantly [206]. Syntaxin-11 had not been addressed 
in that study. Of note, as shown in Figure 5, the increase in cytotoxicity starts 
already after very few hours. We assume in general that the gain in function is based 
on equivalent mechanisms in healthy and FHL cells, as it is not known that FHL 
lymphocytes would suffer from aberrant cytokine signaling or changes in cytokine 
receptor levels. Careful assessment of early time points after cytokine stimulation (4-
8h) would thus greatly contribute important cell biological knowledge on lymphocyte 
exocytosis, because the early compensation phase is most likely based on another 
mechanism than upregulation of compensatory protein levels (which certainly can 
occur at later stages). 
 
The tumorous tissue of the swollen neck had revealed high numbers of infiltrating T 
cells. It was thus suspected that in this case, cytotoxic T cells might be involved in 
the lymphoma control, rather than other immune cells (such as NK cells for 
example). Indeed, EBV specific T cells were identified in the patient PBMC, when 
they had been mixed with an EBV specific peptide (BZLF-1), as they produced TNF, 
whereas heathy control PBMC did not. In many cancers, the anti-apoptotic protein 
Bcl-2 is overexpressed and presented in an MHC class I context. It was shown that it 
has great immunogenic potential, as Bcl-2 reactive cytotoxic T cells have been found 
in patients suffering from several unrelated tumor types [269]. When the current 
patient tissue was analyzed, the RSC indeed were positive for Bcl-2. In summary, 
the patient in this study had developed a classical Hodgkin lymphoma characterized 
by highly immunogenic EBV+ RSC. The reduced degranulation capacity due to the 
genetic defect produces a continuously reduced immunosurveillance in such 
individuals. An interesting question would be why the patient did not undergo a 
second full-blown HLH flare instead of lymphoma development. The RSC were 
immunogenic for a subpopulation of the CD8T cells, which were recruited to the 
tissue. There, they were highly activated, and maybe because they could not 
eradicate the RSC, they were retained in the tissue, producing more cytokines, 
recruiting more lymphocytes, and increasing the tumor mass. This however may only 
represent another wave in the overall disease course. If there had been no medical 
interference at that point, the patient possibly might have progressed into another 
full-blown HLH flare, on top of the lymphoma development.  
 
In summary, this is an interesting case report potentially constituting a link between 
lowered immunosurveillance, a challenging immunological history and the 
development of malignancy.  
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3.2 PAPER II 
 
In this study, we were informed about three patients admitted to a hospital in 
Pakistan, which were suffering from hyperinflammation, and due to the clinical 
values, FHL was suspected. Indeed, the patient cells displayed almost absent 
degranulation and target cell killing in resting state (Paper II, figure 1) whilst the 
healthy controls degranulated readily. The degranulation and killing defect in these 
patients was thus confirmed. Overnight incubation in IL-2 led to partial regain in 
function in the patient cells, and it enhanced function also in the healthy donors, as 
expected. The patients were screened for mutations in the FHL genes UNC13D, 
STX11 and STXBP2. Due to the deficiency in both degranulation and killing, perforin 
was not sequenced. All patients carried a homozygous missense mutation in 
syntaxin-11, p.L58P. None of them displayed mutations in Munc18-2. Patient A 
additionally carried variants in Munc13-4. All patients displayed a dramatic 
degranulation and killing defect, but within the patients, interestingly, the cells of 
patient A were the least capable in resting state. This could further support the notion 
that FHL variants / mutations can add up to each other and consequently increase 
morbidity, lower the age of onset and possibly worsen the disease course.  
 
To evaluate the possibility of syntaxin-11 impacting intracellular fusion events 
needed for cytotoxic granule integrity, an intracellular staining on some key cytotoxic 
granule proteins was performed (Paper II, figure 2). If this would have shown 
abnormal CD107a or granzyme levels for example, that could have been part of the 
mechanism abrogating target cell killing. Additionally, it would have been reminiscent 
of syntaxin-11 fulfilling a role in endosome-lysosome fusion processes in 
macrophages [239], even if in the macrophages, syntaxin-11 had a negative 
(regulatory) role. However, normal levels of perforin, granzyme B and CD107a 
suggested that syntaxin-11 does not couple to cytotoxic granule integrity.  
 
The p.L58P mutation in syntaxin-11 is particularly intriguing from a mechanistic point 
of view. Mutations residing in the SNARE domain can affect the formation of the 
SNARE complex, or for example interfere at a later step, such as dissolving the 
complex and re-sorting of components. Mutations which truncate the protein can 
yield loss of important features such as membrane-binding capacity. This could in 
turn lead to disturbed trafficking. The p.L58P mutation is a point mutation residing in 
the presumable Ha domain of syntaxin-11. We were curious whether the protein was 
expressed and whether it could still interact with Munc18-2, since both, syntaxin N 
peptides and Habc domains, harbor interaction sites for Munc18 proteins. We 
employed cells from patient C, which harbors the syntaxin-11 mutation solely.  The 
amount of patient blood available was not sufficient for isolation and Western blot 
analysis of primary, resting NK cells. Thus, we decided to start with analysis of 
PBMC, being aware of the fact that this is a mixture of cell types. However, in these 
lysates we noted that syntaxin-11 was almost entirely absent, whilst Munc18-2 was 
not affected in the patient (Paper II, figure 3). Some PBMC were then used to 
isolate very low numbers of NK cells and grow LAK cells (Lymphokine-activated 
killer cells). LAK cells are grown on irradiated feeder cells, and maintained amongst 
others in IL-2 and the mitogen PHA-L. That way, the NK cells are continuously 
activated and at some point overgrow the irradiated feeders. The result is a highly 
activated, primary NK cell-derived culture. Keeping this in mind, we analyzed the 
lysates for protein expression, and found no syntaxin-11 expression. 
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In healthy cytotoxic lymphocytes, even overnight stimulation with pro-inflammatory 
cytokines can suffice to pronouncedly enhance syntaxin-11 levels, and even more 
so, syntaxin-11 is upregulated in LAK cells compared to freshly isolated NK cells 
(Figure 9). Obviously, the genetic defect in the patient LAK cells is still inevitable, 
but one possibility could have been that the substantial increase in syntaxin-11 
expression seen in healthy lymphocytes could occur in patient cells, too, and a 
Western blot might allow for diminutive residual protein detection. That is, for 
example, if the mutant protein turnover would not be as fast as its cytokine-driven 
increased production, or not as stringently regulated (like in healthy cells allowing for 
syntaxin-11 upregulation and maintenance under pro-inflammatory cytokines). 
However, we could not detect syntaxin-11, whereas Munc18-2 was comparable to 
controls, similar to the PBMC results (Paper II, figure 3). This clearly indicates that 
the protein is unstable in the patient cells, and massive cell activation due to 
cytokines and other factors cannot even partially stabilize syntaxin-11 p.L58P.  
 
As observed for other FHL4 patients, Munc18-2 is perfectly expressed in these cells. 
This is interesting because it could indicate several important things. First, the 
mutant syntaxin-11 protein likely cannot be stabilized by Munc18-2 anymore, which 
may indicate reduced binding quality. Second, we know that syntaxin-3 is greatly 
upregulated in LAK cells whilst barely detectable in freshly isolated NK cells 
(Figure 9), and Munc18-2 can bind syntaxin-3 (Figure 7), via its Habc and its N 
peptide domains [270]. On top of that, syntaxin-3 might be maintained in Munc18-2 
deficient cells, which makes it a valid candidate to be tested for the pro-inflammatory 
cytokine-induced compensatory mechanism [23]. It was published that syntaxin-11 N 
peptide has a much higher binding affinity for Munc18-2 than that of syntaxin-3 [268], 
but given the high levels of syntaxin-3 and the likely impaired interaction between 
syntaxin-11 and Munc18-2, syntaxin-3 might easily outcompete syntaxin-11 in such 
LAK cells, which can further promote the degradation of the mutant protein. The 
same paper [268] also suggested that Munc18-1 could be able to compensate for 
Munc18-2 in FHL5 patients, when the cells are stimulated with IL-2 ex vivo. If this 
was true and pro-inflammatory cytokines would trigger Munc18-1 expression, it is 
expressed in LAK cells, and available for syntaxin interactions. That in turn could 
implicate that syntaxin-11 has similar binding requirements for both Munc18 
proteins, because otherwise it could bind to Munc18-1 instead in these LAK cells, 
and get stabilized through that interaction.  
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Figure 9. (Left) Untransfected or syntaxin-3 transfected HEK293 cells, resting (Rest) or IL-2 stimulated 
NK cells, LAK cells or resting vs. SEA-stimulated bulk CD8T cells were lysed and blotted with an antibody 
against syntaxin-3. Even though protein loading was not even in this experiment (see actin), none of the 
primary cell lysates displayed a detectable signal for syntaxin-3. (Right) Similarly, the same lysates 
(exchange of the syntaxin-3 to a syntaxin-11 transfected HEK293 control) were blotted for syntaxin-11 
and Munc18-2. A densiometric analysis of the right blot, with protein levels normalized to actin, is shown 
below. Untx, Untransfected; Rest, resting; LAK, lymphokine-activated killer cells; SEA, Staphylococcus 
aureus enterotoxin A. 
 
The mutation might thus destroy an important interaction site for Munc18-2, hence 
we wanted to test its interaction with Munc18-2. Given the number of syntaxin family 
members, and their Habc domain being important for one of the binding modes with 
Munc18 proteins, we first compared the amino acid environment corresponding to 
the L58 position in different syntaxins. Aligning the entire N terminal domains of 
syntaxins revealed that the closest relatives to syntaxin-11 are syntaxin-19, -1, -2, -3, 
and -4 (Paper II, figure 4a). When we matched the amino acid sequences 
surrounding the L58 position, we saw that the leucine is conserved on syntaxin-19, -
1B and -4, whereas syntaxin-1A, -2 and -3 carry an isoleucine at this position (Paper 
II, figure 4c), which is structurally very similar to leucine. Both amino acids are 
uncharged and nonpolar. Aligning only the very N termini corresponding to the N 
peptide in syntaxin-1, we saw that there are three positions which display high but 
not complete conservation, over all syntaxins: D3, R4 and L8. In the syntaxins being 
most similar to syntaxin-11 these are almost entirely conserved. We were thus 
curious to simultaneously study Munc18-2 interaction with another N-terminal 
mutant, this one residing in the N peptide, which might possibly also affect the 
binding with Munc18-2 [189]. Syntaxin-11 p.R4A was cloned onto the same 
backbone as syntaxin-11 wt and p.L58P. Similarly, as a C-terminal mutant control, 
we mimicked the syntaxin-11 mutant which is truncated after the SNARE domain 
(see Figure 8), and has been linked to FHL4 [32]. The protein encodes a 
nonsense mutation yielding syntaxin-11 p.Q268X. For this mutant, we would not 
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expect a defect in binding to Munc18-2, unless the interaction could only take place 
in context of a physiological membrane environment. As a side remark, interestingly, 
this mutant was also seen to be highly unstable in patient PBMCs [32]. Thus, correct 
interaction with Munc18-2 may not be the only determinant of syntaxin-11 stability, 
despite possibly being important.  
 
Regarding protein stabilities, we observed that simultaneous overexpression of 
Munc18-2 and different versions of syntaxin-11 can induce different Munc18-2 
expression levels (see Figure 8). Since we observed this repeatedly, in order to 
equalize the protein input levels for the Co-IP, we decided to express the proteins in 
different batches of HEK293 cells, followed by precipitation of the syntaxins, and 
subsequent exposure of the IP to the lysates containing Munc18-2 (Paper II, figure 
4d, e). Thus, each reaction is offered the same amount of Munc18-2 and, due to 
pulling down syntaxins based on the N-terminally fused tags, there is no bias in how 
well the antibody would bind to the different syntaxin-11 variants. All variants 
expressed well. The Co-IP revealed that indeed, syntaxin-11 wt can bind Munc18-2 
under these conditions. Similarly, the truncation mutant pulled down Munc18-2. 
However, both N terminal mutants could not bind to Munc18-2. Thus, in fact, the 
position L58 is crucial for the interaction with Munc18-2, and equally, the interaction 
is based on an integer N peptide. One report showed that total abrogation of the first 
12 amino acids of syntaxin-11 did neither impair the interaction of recombinant 
syntaxin-11 / Munc18-2, nor when the proteins were overexpressed in HEK293 cells 
[268]. That is interesting, since, regarding our results; it could mean that disturbing 
the N peptide interaction is “worse” than not possessing an N peptide at all. It does 
however not imply that the N peptide would be negligible in cytotoxic lymphocytes. It 
specifically shows that an interaction without N peptide is possible in vitro. When the 
first reports appeared about the structure of syntaxin-1 it became clear that the N 
terminal part harbors three alpha-helical regions which can fold to a helical bundle, 
with a highly conserved outer long groove spiraling around the bundle [271]. That 
groove was suggested to play a role in either SNARE domain binding within the 
same molecule, or allowing for interaction with Munc13 or Munc18 proteins. Within 
and between these three helices (Ha, Hb and Hc), many amino acids are highly 
conserved between species and several syntaxin members. It was found that 
isolated syntaxin-1 adopts a closed conformation wherein the SNARE domain folds 
back onto the N-terminal helix bundle [178]. It might be that the syntaxin-11 p.L58P 
mutation impairs binding of Munc18-2 to the closed conformation of syntaxin-11. 
That was based on the idea that syntaxin-11 L.58P potentially may never adopt a 
completely closed conformation, because the proline substitution could interfere with 
helicity of the domain and introduce a sterical block to the tight binary interaction 
[272]. The results clearly show that sole interaction with the N peptide is not 
sufficient for maintaining interaction with Munc18-2. But it could for example initiate 
it, additionally or synergistically stabilize it, or in another way add up to the binding 
strength. Disrupting the syntaxin-1 closed conformation with the mutation in the 
linker domain (LE mutation) between Habc and SNARE domain led to dramatic 
reduction of Munc18-1 binding, but not SNAP25, complexins or synaptobrevin-2 
[178, 261]. Unexpectedly, in the first study, the mutant protein supported stimulated 
exocytosis in transfected PC12 cells, and the second study added that the mutant 
slowed down the kinetics of release whilst increasing the quantal size. In total, 
constitutively open syntaxin-1, which mostly loses interaction with Munc18, could 
thus still support exocytosis, even with aberrant features, including an aberrant 
subcellular distribution [273]. However, all three studies observed residual interaction 
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between the proteins. In our case of the syntaxin-11 patient mutation, the interaction 
was entirely lost.  
 
Of note, many studies regarding syntaxin-SM protein interactions and analysis of 
mutant and variant proteins have been conducted using transient overexpression 
systems, cell-free recombinant proteins, in vitro fusion assays or similar, but barely 
primary patient material. If there was a patient carrying a homozygous constitutively 
open syntaxin-1 (LE), the protein would likely be considerably instable in vivo, based 
on the substantial loss of interaction with Munc18, similar to what we observe for the 
syntaxin-11 p.L58P mutant (which, too, overexpresses decently in cell lines (see 
Figure 8) and activated primary CTL, unpublished obs.). One study analyzed 
syntaxin-1a wt or KO mice, which additionally carried the LE mutation on syntaxin-
1b. The mice were viable but after some months succumbed to seizures [274]. As a 
side remark, referring to the discussion of Paper I and Figure 8, it was interesting 
to see that in these mice, Munc18-1 levels were found to be decreased upon 
expression of the LE mutant, no matter whether syntaxin-1a was present. All other 
tested exocytosis proteins besides syntaxin-1 itself, were normal. As expected, the 
open syntaxin-1b revealed a dramatically reduced interaction with Munc18-1, but not 
SNAP25, VAMP2 or synaptophysin-1. Thus, interfering with the sterical freedom of 
the Habc domain folding greatly affects vesicle fusion behavior. Along those lines, 
some data indicates that integrity of the entire Habc domain of syntaxin-1 is 
important for trafficking syntaxin-1 correctly to the plasma membrane [275].  
 
It would be very insightful to generate a crystal-structure –based model of syntaxin-
11 p.L58P to gain a better understanding of its folding and its capability also to 
interact with other proteins. In experiments overexpressing syntaxin-11 variants or wt 
in HEK293 cells, when co-expressing SNAP23, we did not detect an interaction 
defect of that mutant. Thus, the lack of Munc18-2 interaction likely does not impact 
the binding of SNARE partners for this mutant. Another curious protein to test 
syntaxin-11 p.L58P interaction with would be Munc13-4. It is, like Munc18, not a 
SNARE protein, but an important regulator of fusion. It binds to calcium which 
couples it to cell activation, and it can bind to the syntaxin-11 SNARE domain [232]. 
In fact, it might bind even stronger to syntaxin-11 p.L58P in a co-expression system, 
because the closed conformation might be impaired making the SNARE domain 
more accessible. However, this remains to be shown. A mutant corresponding to the 
syntaxin-11 p.L58P mutation has not been reported on syntaxin-1, but the site is 
conserved, and that could also mean that it represents an essential binding site in 
general for Munc18 interaction. A less disruptive artificial mutation should be 
generated on this position, for example syntaxin-11 (and syntaxin-1) p.L58A 
(p.L47A), and the interaction with Munc18-1 and -2 should be tested, for both. That 
way, one could address if abrogation in binding is due to sterical hindrance due to 
reduced helix packing, or due to an amino acid-specific mechanism. It might also be 
worth testing syntaxin-11 p.L58P in a liposome fusion assay. One study showed that 
even if syntaxin-1 is only consisting of N peptide, SNARE domain and 
transmembrane domain, it is capable of mediating fusion [207]. The syntaxin-11 
Habc domain might thus possibly not be involved in fusion, and rather play a role for 
stability, trafficking or other protein features. Alternatively, similar to the discussed N 
peptide necessity, also for the Habc domain, a curious idea could be that having no 
Habc domain at all is still allowing for fusion in vitro, whereas bearing a sterically 
interfering Habc domain may not allow for fusion. That remains to be addressed, and 
both, mediating and not mediating fusion, are potential outcomes. 
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Since the p.L58P protein is unstable and possibly never reaches the plasma 
membrane before it is degraded, it cannot mediate fusion in a physiological setting. 
Besides that, it cannot interact properly with Munc18-2, and if Munc18-2 would fulfil a 
docking role for cytotoxic granules in the lymphocytes, that function, too, could be 
abolished by this mutant. Even if it would be “fusion-competent” in vitro, syntaxin-11 
p.L58P is still fusion-deficient in vivo. The syntaxin-11 p.R4A mutation in vivo might 
also not be able to mediate the terminal fusion reaction, and that would be consistent 
with the previous study, as well as the observation that the probability of vesicle 
fusion in transfected PC12 cells was coupled to the quality of the N peptide 
interaction with Munc18 [276]. Similarly to what has been found for the syntaxin-11 
p.Q268X patients [32], truncated syntaxin-1, which lacks the transmembrane 
domain, could also not mediate exocytosis [178], presumably because it can 
sequester Munc18-1 from the plasma membrane, and the localization of both 
proteins is aberrant. A FRET-based study showed that syntaxin-1 localization to the 
plasma membrane is dependent on Munc18-1 when overexpressing the proteins in 
HEK293 or adrenal chromaffin cells [273]. Similarly, another study showed that 
truncated syntaxin-11 p.Q268X loses membrane association when overexpressed in 
an NK cell line (YTS cells) [237]. Of note though, when we overexpressed that 
truncation mutant in stimulated, primary CD8T cells, it was observed in several 
donors that some cells present with a vesicular phenotype of that mutant, 
additionally to the free cytoplasmic distribution (unpublished obs, and [237]). There 
might thus be other protein-protein interactions which determine syntaxin-11 
localization in primary cells, at least partially independent of its palmytoylation sites.  
If syntaxin-11 trafficking in primary cytotoxic lymphocytes is dependent on Munc18-
2, and more detailed, which domains mediate its trafficking, need to be addressed in 
more detail.  
 
On a final note regarding protein stability, there was an interesting article which 
studied the overall maintenance of wt syntaxin-11 in the context of proteasomal 
integrity [247]. They found that, in NKL, syntaxin-11 maintenance is dependent on a 
functional proteasome, while Munc18-2 levels were not affected by the inhibitors. 
This was not due to decreased syntaxin-11 mRNA expression. Syntaxin-11 
remained stable when the cells were treated with lysosome acidification or tripeptidyl 
peptidase II inhibitors. But incubation with pan caspase inhibitors increased syntaxin-
11. Thus, a functional proteasome supports syntaxin-11 levels, whilst syntaxin-11 
levels can be limited by caspases. As an explanation for this, it could be that 
proteasome activity normally keeps the expression level of caspases in check, which 
secures syntaxin-11 expression in healthy cells. Also, proteasome inhibitors could 
stress the cells to an extent which activates caspases, leading to degradation of 
syntaxin-11.  Of note, the effect of the proteasome inhibitor was stronger on NK cells 
than on CTL. This could imply an additional level of regulation which is different 
between lymphocyte subsets. 
 
In summary, we have shown that N terminal syntaxin-11 point mutations in N peptide 
and Habc domain both can completely disrupt the binding to Munc-18-2. The loss of 
this interaction causes syntaxin-11 p.L58P instability and a profound defect in 
cytotoxic granule exocytosis. Further N terminal mutations will help to elucidate the 
exact interaction surfaces on syntaxin-11 and hopefully provide more mechanistic 
knowledge on the similarities and peculiarities of the syntraxin-11 - Munc18-2 
interaction compared to other syntaxin - SM protein pairs. 
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3.3 PAPER III 
There are several studies on VAMP proteins in cytotoxic cells and cell lines but it is 
still not clear which VAMP protein mediates the exocytosis of cytotoxic granules in 
human cytotoxic lymphocytes. In this study we addressed whether VAMP8 could be 
the v-SNARE for this process in human cytotoxic cells. To that end, we first set out to 
confirm if the protein is expressed in human CTL. VAMP8 was readily expressed in 
resting and TCR-stimulated cells, with transcript as well as protein levels increasing 
upon TCR stimulation. Here, the CTL had been stimulated with magnetic beads 
covered in anti-CD3 and anti-CD28 antibodies, to achieve massive cell activation ≥ 
2-3 days. Alternatively, SEA was used as potent stimulant for CTL, also increasing 
the level of VAMP8 expression (Paper III, figure 1). When we then looked at 
endogenous or overexpressed VAMP8 (side remark: all experiments in this study 
were conducted with wt proteins) in these cells, VAMP8 was observed in a punctate 
pattern under the plasma membrane and in the cytoplasm all over the cell when the 
cells were not conjugated to target cells. In conjugates, VAMP8 localized to the 
contact site, which supported the notion that it might be implicated in cytotoxic 
granule release. We tested whether VAMP8 would co-localize with cytotoxic granule 
proteins such as granzymes or perforin. However, VAMP8 did not localize on 
cytotoxic granules, neither in non-conjugated cells, nor in conjugates with target 
cells.  Thus, surprisingly, VAMP8 is likely not the R-SNARE serving for cytotoxic 
granule fusion in human CTL. Subsequently, we co-transfected CTL with markers of 
early, late and recycling endosomes (Rab5a, -7a and -11a, respectively) together 
with VAMP8, to gain insight into which compartment VAMP8 localizes to. The protein 
was found mostly on recycling endosomes (marked by Rab11a) with minor fractions 
residing on early and late endosomes (Paper III, figure 3). These experiments were 
conducted on fixed cells in SIM microscopy. However, we were curious whether 
VAMP8 and Rab11a would co-localize throughout synapse formation, if the 
distribution and dynamics of the two proteins would be identical and if these vesicles 
fused with the membrane in the immunological synapse. Therefore, CTL co-
transfected with VAMP8 and Rab11a were allowed to form synapses on anti-CD3 / 
CD28 coated glass surfaces, and imaged live in TIRF microscopy. This allowed us to 
gain insights on the molecular dynamics in the area within and immediately above 
the plasma membrane. Directly after the cells sedimented and spread out to form 
immunological synapses, VAMP8+Rab11a+ vesicles of variable sizes became 
visible within the TIRF plane. As seen in Paper III, figure 4a, most of these vesicles 
revealed a striking co-localization between the proteins, and individually measuring 
vesicle dwell times and numbers accumulating at the synapse, both proteins showed 
very similar characteristics (Paper III, figure 4b, c). These movies also revealed that 
a number of rapid fusion events of these vesicles occurred soon after the cells had 
sedimented and spread out (Paper III, figure 4d, e). By cloning fusion proteins 
consisting of VAMP8 with its transmembrane domain fused to monomeric teal 
fluorescent protein (TFP), with or without a 3x FLAG tag in between, we were able to 
analyze this type of VAMP8+Rab11a+ vesicle exocytosis in multicolor flow cytometry 
(Paper III, figure 4f, g). Furthermore, constructs of VAMP8 fused to lumenal 
mCherry and pHlourin were cloned which allow for sensing the fusion events. This is 
because the pHlourin is not fluorescent in acidic environments, but starts to fluoresce 
in neutral pH. Once exocytosis of the Rab11a+VAMP8+ vesicles would occur, the 
pHlourin would start to fluoresce. In both, the flow cytometry assay and the 
microscopic analysis of the constructs, and in line with the previous data, stimulated 
exocytosis of these vesicles was observed.  
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For the VAMP8+pHlourin+ vesicles which fused after entering the plasma 
membrane proximity (TIRF plane), a sharp peak in pHlourin fluorescence 
simultaneously to the peak in mCherry was seen upon exocytosis (Paper III, figure 
4h, left). However, some vesicles had different fusion kinetics, wherein fusion was 
not immediately followed by dispersion of pHlourin fluorescence. This could indicate 
that the types of fusion which such vesicles can undergo are heterogeneous, with 
some resembling full collapse whilst others might resemble kiss-and-run type of 
exocytosis (Paper III, figure 4h, right). That would be in line with results gained with 
pHlourin-based exocytosis experiments in an NK cell line, NKL [277]. However, this 
needs further exploration.  
 
The data so far showed that VAMP8 occupies a preponderant portion of the 
recycling endosomes, and TCR stimulation can trigger recruitment and exocytosis of 
such vesicles. To gain further insights into the dynamics of VAMP8+Rab11a+ versus 
cytotoxic granules, CTL were co-transfected with VAMP8-TFP and perforin-mCherry, 
and imaged in the TCR-stimulating TIRF system, as before. Interestingly, we 
observed that VAMP8 reached the plasma membrane first; followed by perforin a 
few seconds later (Paper III, figure 5a-c). The VAMP8+ vesicles outnumbered 
perforin+ vesicles in this system. However, one should keep in mind that the proteins 
might have different turnover times and they might be differently tolerated by the 
lymphocytes. The overexpression system might thus not exactly mirror the 
physiological protein amounts. The VAMP8+ vesicles fused within the first few 
seconds after entering the TIRF plane, whilst perforin vesicles displayed a 
significantly increased dwell time, before they either fused or withdrew out of the 
TIRF plane (Paper III, figure 5b). On top of that, on average only very few perforin 
vesicles fused (<10) whilst many VAMP8+ vesicles fused (>40) per imaged cell. 
These data further confirm that VAMP8+ and perforin+ vesicles follow different 
kinetics and are at no point during synapse formation, recycling endosome or 
cytotoxic granule exocytosis equivalent. The intriguing question was now, as 
apparently VAMP8 did not mediate cytotoxic granule fusion - what other fusion 
events could it mediate at the synapse, occurring right upstream of cytotoxic granule 
exocytosis, imparted via recycling endosomes? And would these events be 
functionally coupled at all? 
 
To first test if recycling endosome or cytotoxic granule release is dependent on 
VAMP8, the protein was knocked down with siRNA against VAMP8 in the CTL which 
simultaneously were overexpressing either Rab11a-mCherry or granzyme B–
mCherry, respectively, and imaged in TIRF microscopy (Paper III, figure 6c-g). This 
time, granzyme B was chosen over perforin because the cells tolerate granzyme B 
transfection better than perforin transfection. Interestingly, we found that the 
knockdown of VAMP8 impaired recycling endosome fusion with the plasma 
membrane (Paper III, figure 6d) but the vesicle dwell times were comparable. This 
can mean that recycling endosomes which enter the TIRF plane either undergo 
exocytosis within a given time frame (approximately 20 s), or they withdraw again 
from the synapse, moving back into less proximal cytoplasmic areas (Paper III, 
figure 6c). As a note on the side, of course it cannot be excluded that such vesicles 
re-enter the TIRF plane after some time, which would then be recorded as a “new” 
vesicle.  
 
Looking at VAMP8 knockdown in cells overexpressing granzyme B, we again found 
that the granzyme B+ vesicle dwell time was not affected significantly, but there was 
a sharp, significant decrease in granzyme B+ vesicle fusion events (Paper III, figure 
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6f, g). CTL with control or VAMP8 siRNA were also tested in a standard functional 
flow cytometry assay (degranulation assay) based on TCR stimulation, where CTL 
normally release cytotoxic granules and display the granule-associated protein 
CD107a on their surface. CD107a can then be stained and serves as a surrogate 
marker for exocytosis. This is the same procedure as the degranulation assays 
conducted on the lymphocytes of the FHL patients discussed in the previous articles 
(Paper I and II). Lack of VAMP8 significantly reduced cytotoxic granule release 
(Paper III, figure 6h, i). VAMP8 is thus required for both, recycling endosome and 
cytotoxic granule exocytoses, and the latter effect is due to the previous effect. To 
exclude the possibility that VAMP8 would also play a role in upstream signaling 
events such as calcium flux or TCR signaling-induced phosphorylation events, the 
VAMP8 knockdown CTL were assayed for phosphorylation of ERK, an early TCR 
signaling event, and calcium influx from the medium with a calcium-sensitive dye 
(Paper III, figure 7a, b). The VAMP8 knockdown CTL showed no aberrant ERK 
phosphorylation or calcium mobilization, indicating that VAMP8 plays no role in early 
TCR signaling. Another parameter that we tested was the spreading characteristics 
of VAMP8 knockdown cells, because it was possible that lack of VAMP8 and lack of 
recycling endosome fusion would impact synapse integrity, size or for example actin 
mesh dynamics. However, we could not detect obvious changes in actin dynamics or 
synapse morphology (Paper III, figure 7d-f).  
 
One possible function of the VAMP8-mediated recycling endosome fusion events 
could be that VAMP8+Rab11a+ vesicles would deliver proteins to the plasma 
membrane which are subsequently needed for cytotoxic granule release. One key 
protein for this delivery could for example be syntaxin-11. A previous study showed 
that syntaxin-11 localizes to recycling endosomes and is transported to the 
immunological synapse before the cytotoxic granules arrive [245]. Therefore, 
VAMP8+ recycling endosomes might transport syntaxin-11 to the immunological 
synapse on demand, so it can mediate cytotoxic granule exocytosis once the 
cytotoxic granules arrive. Indeed, we observed that VAMP8 knockdown produced a 
significantly increased syntaxin-11+ vesicle dwell time at the synapse, accompanied 
by accumulation of syntaxin-11 vesicles over time, and the fluorescence dispersion 
events indicative of fusion were markedly reduced (figure 7g-k). VAMP8 and 
syntaxin-11 fusion mostly occurred in the center of the immunological synapse, likely 
corresponding to the central synapse region which is the site of cytotoxic granule 
exocytosis (see chapter 1.2.4). However, this was only a trend, and a considerable 
number of dispersion events occurred in peripheral synapse regions (approximately 
20-40 %, Paper III, figure 7l-n). When analyzing syntaxin-11 distribution in VAMP8 
knockdown cells, surprisingly we found syntaxin-11 to cluster even more in the 
central region of the synapse than in corresponding control cells (Paper III, figure 
7o). It is thus possible that in healthy cells syntaxin-11 adopts a specific distribution 
inside and outside of the central synapse region, and this balance may have 
functional consequences for cytotoxic granule exocytosis.  
 
In summary, the hypothesis is that syntaxin-11 is trafficked by VAMP8-dependent 
fusion events on a population of recycling endosomes, and deposited at the 
immunological synapse, ready for mediating exocytosis of cytotoxic granules (Paper 
III, figure 8). Syntaxin-11 is only one of the proteins needed for cytotoxic granule 
secretion in CTL and NK cells. It is thus possible that VAMP8+Rab11a+ vesicles 
deliver other exocytosis mediators, too. One interesting candidate to test would be 
Munc18-2, given that syntaxin-11 and Munc18-2 might co-traffic, similarly to the 
neuronal pendants, syntaxin-1 and Munc18-1. Munc13-4 and Rab27a coordinate 
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and / or traffic on recycling endosomes, too [262, 263], cytokines have also been 
linked to recycling endosome-mediated transport [250]. It remains to be shown if all 
of these are separate recycling endosome populations, and how these pools are 
coordinated. 
 
The observation that VAMP8 mediates syntaxin-11 deposition at the synapse 
instead of being the v-SNARE for cytotoxic granule fusion was surprising in some 
ways. Syntaxin-11 has been shown to interact with VAMP8 and SNAP23 in platelets 
[238]. However, we could not detect VAMP8 co-immunoprecipitating with syntaxin-
11 in lysates of primary cytotoxic lymphocytes (unpublished obs.). The observation 
that VAMP8 did not reside on cytotoxic granules but instead on recycling endosomes 
outruled this possibility. It remains to be shown which other VAMPs, for example 
VAMP3, -4 or -7, play roles in human cytotoxic granule fusion in primary 
lymphocytes, and if so, which exact fusion event they participate in. Given that there 
is no VAMP deficiency causally linked to cytotoxic granule exocytosis, it is also 
possible that, either, several VAMP proteins act in concert in this process and can 
functionally compensate for the loss of one VAMP, or, a specific cytotoxic granule 
exocytosis VAMP exists, but it has crucial roles in other cell types, too, and thus 
deficiencies could be embryonically lethal. Combinations of VAMP knockdowns or 
knockouts in primary human lymphocytes are needed to evaluate this question in 
more detail.  
 
Regarding the considerable recycling endosome recruitment, an interesting idea is 
whether, additionally to delivering syntaxin-11 (and maybe other exocytosis 
proteins), there could be other roles for the VAMP8+Rab11a+ exocytosis exactly 
prior to cytotoxic granule fusion, meaning exactly prior to destructive protein release 
into a “non-directional” (diffusion-based) synaptic cleft. Once perforin is released and 
adopts its functionally active form in the synaptic cleft, there must be mechanisms to 
ensure membrane protection in the cytotoxic lymphocytes. CD107a has been 
suggested to play a role in lymphocyte protection from perforin [278], and another 
article implicated Rab11 and Rab5 in membrane repair mechanisms upon treatment 
of intestinal epithelial cells with pore-forming bacterial toxins [279]. Producing 
substantial recycling endosome trafficking at the immunological synapse might thus 
possibly also serve as a highly dynamic membrane repair system to ensure 
membrane integrity. However, this idea needs further exploration. Additionally, of 
course, coupled to the outward membrane flux that occurs upon exocytosis of 
VAMP8+ vesicles and cytotoxic granules, the recycling endosomes could also aid in 
retrieving membrane and membrane constituents during and after exocytosis (see 
also [280]). If recycling endosomes also organize the retrieval of syntaxin-11 (and 
maybe Munc18-2) after killing is completed, remains to be addressed.  
 
Another very interesting question remaining unresolved is why syntaxin-11 would 
stay associated with VAMP8+ recycling endosomes and not be deposited at the 
plasma membrane constitutively in primary lymphocytes. Other syntaxins such as 
syntaxin-1 are transported to and maintained at the plasma membrane where they 
can serve their function in exocytosis without delay. In contrast, syntaxin-11 and also 
Munc18-2 are mostly found intracellularly, even in activated, pro-inflammatory 
cytokine-stimulated cells or LAK cells (unpublished obs.). The VAMP8-Rab11a-
dependent syntaxin-11 transport exactly into the immunological synapse might for 
example be a mechanism preventing any standby exocytosis events at non-
conjugated plasma membrane sites. In this context, it could be informative to 
generate a syntaxin-11 construct which bears the membrane anchor of syntaxin-1 in 
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transfected cytotoxic lymphocytes, or a hybrid construct consisting of syntaxin-11 
fused to the transmembrane part of an unrelated plasma membrane-resident protein. 
It remains to be shown whether in such cells, cytotoxic granule exocytosis would still 
occur to the same extent and in a targeted fashion.  
 
In this context, it would also be very informative to follow VAMP8 and syntaxin-11 in 
anti-CD16 stimulated NK cells. Even though unlikely to occur as an isolated stimulus 
in a physiological setting, CD16 stimulation alone lead to non-polarized 
degranulation of cytotoxic granules [107]. However, the amount of syntaxin-11 
approximately doubles when resting NK cells are seeded onto IgG-coated glass 
surfaces and imaged in TIRF microscopy, and the gain in fluorescence intensity over 
the synapse area was significant (unpublished obs.). Syntaxin-11 is thus responsive 
to CD16 stimulation and is recruited towards the immunological synapse, but the 
recruitment may not be limited to the synapse area. This would mean that certain 
signaling pathways might promote VAMP8+syntaxin-11+ vesicle exocytosis in a non-
polarized fashion, whereas others might promote polarized recycling endosome 
trafficking, which most likely couples to cytoskeletal elements such as microtubules 
and MTOC. Another intriguing idea could of course be that non-polarized secretion 
of cytotoxic granules is also microtubule transport-based, but for some reason in an 
anterograde (plus-end) -directed fashion, away from the immunological synapse. If 
this is a transport mechanism resembling the non-polarized exocytosis which can 
occur for cytokines [250], remains to be addressed.  
 
Looking at our findings from another angle, we have established that VAMP8 
delivers syntaxin-11 to the plasma membrane on demand. However, besides the 
question which VAMP serves as v-SNARE for cytotoxic granule release, we similarly 
do not know yet which SNARE complex mediates fusion of the syntaxin-11+ 
recycling endosomes, or if syntaxin-11 itself is implicated in this. Syntaxin-11 is also 
not exclusively found on recycling endosomes. It should be noted that, additionally to 
VAMP8 and Rab11, we have observed a high co-localization of syntaxin-11 with 
Rab5 and Rab7 as well as Munc18-2 (unpublished obs.), and this pattern could be 
aberrant for some of the mutants. Further studies need to be performed on the 
trafficking of syntaxin-11 and Munc18-2 to understand their complicated relationship 
and how some variants and mutations can interfere with functionality of cytotoxic 
lymphocytes. All these exciting questionings remain to be addressed carefully. Such 
data will hopefully provide essential knowledge about subcellular transport and 
exocytosis processes in cytotoxic lymphocytes, and help us to better understand 
how these processes are coordinated before, throughout and after target cell killing, 
in order to prepare for a new round of killing, or even understand why some 
lymphocytes in a given (healthy) population can kill several target cells serially whilst 
others do not [281-283].  
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4 CONCLUSIONS AND FUTURE DIRECTIONS 
 
“After climbing a great hill, one only finds that there are  
many more hills to climb.” 
(Nelson Mandela) 
 
 
 
Understanding how variants and mutations affect cellular functions and can cause 
disease is a tremendous challenge in medical research. Particularly, it is important to 
elucidate even very subtle details about protein-protein interactions and their 
implications for protein stability, localization and protein activity. The more variants 
and mutations are described, the better we can focus on detailed genotype-
phenotype correlations representing mutations mapped to their individual protein 
domains and interactomes, in relation to patient cell behavior, morphology and 
function. Simultaneously, the more we can learn about the variant and mutant 
proteins, the more knowledge can accumulate about the wt proteins, too.  
 
It has been long understood that a systemic, comprehensive disease like FHL 
requests information on several different layers. Studies on the single cell level can 
amongst others provide insights into protein interactions and trafficking. Studies on a 
cell population level will help us to understand more collective processes 
determining disease outcome and intercellular communication, including protein 
expression or cell degranulation and cytotoxicity against susceptible targets. Studies 
looking at tissue morphology, immune cell infiltration and production of inflammatory 
mediators as well as pathogen-derived mediators (for example in an EBV+ 
background) help to elucidate cell communication in an acute inflammatory tissue 
environment setting. From these data, we can learn more about overall tissue 
pathology determining organ function and leading to very aggressive or more slow 
tissue destruction, which in some cases can even lead to cell transformation. And 
furthermore, looking at medical records of patients from different geographic and 
ethnic origins can for example help to identify founder mutation effects and at some 
point possibly demonstrate if also more peripheral or external factors such as non-
FHL related immunological history, lifestyle or other factors could play a role during 
disease progression.   
 
The three articles introduced here include several important patient cases suffering 
from loss of functional Munc18-2 or syntaxin-11, respectively. For both proteins, 
there are still numerous variants and mutations which are poorly understood 
mechanistically. Some syntaxin-11 variants for example do not impair interactions 
with Munc18-2, Vti1b or SNAP23, and they may traffic similarly to the wt protein in 
healthy human CTL (unpublished obs.). This indicates that we are still missing out 
on some protein aspects. There is for example little proteomic, comprehensive data 
on FHL protein interactomes which could suggest novel candidates impacting FHL 
protein interactions, localization and stability.  Generally, supporting genetic 
analyses much more with mechanistic data in the future will certainly widen our 
understanding of the FHL cell biology. This addresses for example a few variants 
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which have been found in a heterozygous or compound heterozygous state, but for 
syntaxin-11 it has not been shown how exactly a variant or mutation could act in a 
dominant-negative fashion. 
 
Considering the body of literature from other exocytosis fields opposing the tenuous 
knowledge in the human lymphocyte exocytosis field, there are many concrete open 
questionings for syntaxin-11 and Munc18-2 which deserve full attention. The 
trafficking of both proteins needs to be understood in detail. We still do not know if 
they traffic together, on which compartment they meet, or if they can for example 
form a binary complex co-translationally. From our own observations we know that 
overexpressed syntaxin-11 co-localizes bulky with VAMP8, Munc18-2, Rab11, Rab5 
and Rab7. How dependent this distribution is on Munc18-2, if this distribution is 
physiological in healthy cells or how it differs in patient cells is not known. Similarly, 
which interaction surface between syntaxin-11 and Munc18-2 is responsible for 
which trafficking step is completely unknown, and requires more research. Possibly 
coupled to this, an intriguing question is how the recycling from the plasma 
membrane, as well as the endogenous turnover of syntaxin-11 is organized and how 
the kinetics of these processes is. To that end, the LE mutation could be introduced 
onto syntaxin-11. The positions are almost completely conserved, with an I (Ile) 
instead of a L (Leu), and a conserved E (Glu) at the corresponding residues on 
syntaxin-11. Further, replacing syntaxin-11 palmytoylation sites systemically (for 
example in an alanine scan approach), or introducing a transmembrane anchor 
could yield interesting insights on its membrane attachment requirements and help 
to understand why syntaxin-11, unlike almost all other syntaxins, does not possess a 
transmembrane domain. 
 
The curious observation of partial compensation in FHL4 and some FHL5 patients 
urges to gain more knowledge on such a FHL protein-independent compensatory 
mechanism. Further supplementation and imaging experiments are needed to 
understand which proteins can mediate this function, and if the mechanism is the 
same as what increases functionality in healthy cells. It is possible or even likely that 
besides the suggested candidates (syntaxin-3 and Munc18-1), there are other 
syntaxins and Munc18 proteins which aid, particularly in the initial phase after pro-
inflammatory cytokine stimulation. It is also important to clarify if such compensation 
is at all based on SNARE protein / complex substitution only, or if other factors such 
as for example enhanced cell adhesion or cytoskeletal rearrangements (which also 
occur upon pro-inflammatory cytokine stimulation) play a role in this increased / 
rescued degranulation process. 
 
The third article describes that VAMP8 traffics on recycling endosomes and serves a 
crucial, preparatory role for cytotoxic granule exocytosis, as it delivers syntaxin-11 to 
the plasma membrane. In the future, the role of other VAMPs in cytotoxic 
lymphocytes needs to be addressed carefully, as it is still not understood which 
VAMP protein can mediate cytotoxic granule fusion. For VAMP8 itself it could be 
informative to create hybrid proteins where VAMP8 transmembrane domain is 
replaced by other VAMP transmembrane domains, so that it would be forced onto 
cytotoxic granules, for example. Such experiments could amongst others show if the 
cytotoxic granule fusion is specific for one / a few certain VAMP / VAMPs, or if this 
process is governed by stringent VAMP protein sorting to specific organelle 
surfaces. 
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5 METHODOLOGICAL APPROACHES AND LIMITATIONS 
 
“There were no holds so I had to use skill.” 
(Anonymyous climber) 
 
 
5.1.1.1 Cell isolation techniques 
For all studies, freshly isolated healthy or patient peripheral blood lymphocytes were 
employed for different assays. Cytotoxic lymphocytes are isolated from whole blood 
via differential density centrifugation (for example Ficoll™ gradient) which yields 
layers of polymorphnuclear cells (red blood cells, thrombocytes, granulocytes) and a 
layer of PBMC. The PBMC comprise the cytotoxic lymphocytes. NK cells constitute 
about 5 - 15 % of PBMC. T cells are the majority of PBMC, with approximately 70 %. 
Out of these, approximately 60 % are CD4+ and 40 % are CD8+. For some 
experiments, when pure populations rather than whole PBMC were needed (for 
example for transfection experiments or some Western blots), we isolated cytotoxic 
lymphocyte populations from the PBMC, using negative selection. This is based on 
magnetic beads covered with antibodies which deplete other cell types because 
these remain on the columns. Purity of negatively isolated NK or CD8T cells is never 
100 %, there are typically few other cells contained (< 3 %). However, the negative 
isolation is still suitable for our experiments because, despite lower purity than 
positive selection, we circumvent the possibility that the isolated cells are activated 
by antibody binding to the surface antigen (for example CD3 or CD8). Besides that, 
several other cell types can be distinguished easily by cell size and morphology in 
imaging experiments or flow cytometry, and given their small percentage we could 
still interpret results from Western blots, for example.  
5.1.1.2 Homogeneity and cytotoxicity of CTL and NK cells 
A frequently used, simple definition of NK and CTL are NK cells defined as 
CD56+(+)CD3- and CTL defined as CD3+CD8+CD57+. For our studies on cytotoxic 
granule exocytosis and trafficking of proteins, we focused on cells expressing 
perforin, as it served as our marker for cytotoxic granules. Our rationale was that 
perforin is needed to perform target membrane perforation; hence granules not 
containing perforin can certainly add up to the cytotoxic protein pool in the synaptic 
cleft, but by themselves cannot trigger apoptosis in the target. However, as a 
compromise for some transfection experiments, we employed a construct for 
granzyme B expression rather than perforin because perforin transfection is 
sometimes not tolerated well by the CTL. For the imaging experiments with CTL, we 
isolated bulk CD8T cells which were subjected to magnetic bead-based antibody 
stimulation for 48 h (anti-CD3 / CD28 beads) in enriched cell culture medium. 
Through the intense stimulation, the cells are continuously activated and cytotoxic 
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granule protein expression is induced or enhanced, as many cells within the CD8T 
cell pool do not express abundant levels of perforin per se. This protocol produces 
heavily activated cells but these are still more physiological than any cell line. These 
CTL are much more prone to survive transfection procedures and besides that, the 
bead stimulation increases cell size, adhesion capability and overall vividness, and 
the synapses they form represent preeminently mature cytotoxic synapses. All of 
these traits simplify lymphocyte imaging experiments substantially. Furthermore, 
some differences in syntaxin-11 and Munc13-4 expression were observed in naïve 
versus effector CD8T cells [284]. The intense TCR stimulation reconciles such 
expression differences and drives the entire population to upregulate perforin and to 
mature into a more effector-like population which was suited for our purposes. NK 
cells undergo different developmental stages and accordingly express different 
phenotypical markers, and within the bulk negative NK cell isolation, a number of 
developmental stages are contained. However, for NK cells in healthy donors there 
is data (unpublished obs.) hinting towards a homogenous mRNA expression of 
syntaxin-11, Munc18-2 and Munc13-4 over different developmental stages and also 
adaptive NK cell subsets in resting states. For that reason it seemed redundant to 
separate specific NK cell subsets for the studies conducted in this thesis. We did 
also not observe that cell activation would affect FHL protein localizations 
(particularly syntaxin-11 or perforin), even though in cytokine-activated cells it could 
have been an interesting strategy of cells to enhance cytotoxic granule release by 
speeding up the FHL protein organization at the plasma membrane, and allowing for 
granules to fuse in a less restricted fashion, by providing more potential granule 
docking spots at the plasma membrane. However, we did not see any syntaxin-11 or 
Munc18-2 associated with the plasma membrane, even in heavily cytokine-
stimulated cytotoxic lymphocytes. Of course, we cannot conclude that syntaxin-11 
displays the exact same endosomal compartment distribution in resting cytotoxic 
lymphocytes as compared to our model CTL system, but this model still allows us to 
understand how syntaxin-11 trafficking is regulated by VAMP8 in CTL.  
5.1.1.3 Protein expression inhomogeneity 
 A surprising inhomogeneity within total PBMC regarding syntaxin-11 stability was 
displayed in paper II, when we compared Western blots performed on patient PBMC 
versus LAK cells. As it turns out, there must be non-NK cell populations in which the 
mutated protein is maintained longer than in other cell types, because there was a 
weak band visible in the PBMC Western blot whilst there was absolutely no protein 
in the NK-based LAK population. We could not determine which cell type was 
responsible for the residual syntaxin-11 signal, because the number of PBMC 
typically isolated from such patients is very small, and it is barely possible to sort 
such PBMC into its major components and then perform a Western blot on all of 
these subsets. Identifying the cell type being able to maintain the mutant syntaxin-11 
(p.L58P) might be informative for FHL protein stability studies, for example in respect 
to possible differences in activity of degradative systems, such as the proteasome or 
caspases. It would have been great to compare protein expression in the other 
patients with the same mutation (mostly patient B), to confirm this finding in the other 
patients with the same, or even other syntaxin-11 mutations.  
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5.1.1.4 Genetic modification and protein expression systems 
Overall, a major bottleneck when genetically modifying primary human cytotoxic 
lymphocytes is that transfection protocols can be optimized to some extent, but all 
electroporation-based methods are very detrimental to freshly isolated cytotoxic 
lymphocytes. Transduction protocols can provide better viability and transfection 
efficacy, but the virus stock preparations can be time-consuming and batch 
variations can occur. For overexpression as well as knockdown experiments, a 
major difficulty is that neither of them can completely eradicate the effect of the 
endogenous wt proteins. Knockdowns are rarely absolute, and overexpression per 
se does not affect the intrinsic protein expression, should the protein (as in our case) 
be endogenously expressed by the transfected host cell. Along these lines, of course 
one issue could be that endogenous protein (which is not labeled or tagged) could 
dilute some effects applying to the overexpressed protein. In the case of mutant 
protein overexpression, the mutant protein could for example be outcompeted by 
endogenous healthy protein and thus not represent the patient cell situation well 
(unless the patient is for example heterozygous). However, in our trafficking study 
(paper III) we only applied wt proteins; hence we would possibly expect some level 
of dilution but it would be unlikely that the overexpressed proteins would mislocalize 
because they cannot compete against the endogenous proteins. However, we did 
not address what the ratio of overexpressed to endogenous protein is, thus we 
cannot comment on such effects of overexpression. For research purposes, novel 
genetic manipulation strategies could be helpful to transfer our findings to freshly 
isolated resting cytotoxic lymphocytes. With such technologies, human genes could 
be edited permanently and specifically, ideally without off-target effects. New 
technologies like CRISPR/Cas-based genetic modifications can possibly provide this 
at some point in the future, but until resting, human cytotoxic lymphocytes are 
applicable for such a technique we still need alternative model systems to test the 
behavior of wt and mutant proteins. A frequently used system to study protein 
interactions and possible distribution in mammalian cells are cell lines such as 
HEK293 or HeLa cells. In our studies, we have employed HEK293 cells for protein 
interaction studies. They can be easily genetically modified and can produce a lot of 
protein for testing protein-protein interactions. Producing bacterial, recombinant 
protein might have been beneficial for large scale interaction studies, for example 
when addressing the global syntaxin-11 interactome in cytotoxic cells. For our 
purposes however, the HEK293 system was sufficient. Also, HEK293 are 
mammalian cells, and in case syntaxin-11 would be post-translationally modified this 
is not represented on bacterially produced recombinant proteins, whilst possibly 
maintained in mammalian cells. However, one should keep in mind that recombinant 
protein can also be produced on a large scale in mammalian cells meanwhile, for 
example in trypanosomes.  
5.1.1.5 Co-immunoprecipitation system 
After testing syntaxin-11 and Munc18-2 co-expression followed by co-
immunoprecipitation, we realized that syntaxin-11 and Munc18-2 expression is 
relative to each other and we cannot normalize each reaction input in such a system 
very well. Hence, we switched to a single-construct expression system, still in 
HEK293 cells. This allowed us to lyse batches of transfected cells individually, for 
example one batch expressing Munc18-2, and some others expressing each one or 
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another version of syntaxin-11. That way we were able to provide the exact same 
amount of lysed Munc18-2 to each syntaxin-11, which greatly helps to make such 
Co-IP reactions more comparable. Of course, one has to keep in mind that this 
system favors interactions which can form rather quickly and without a proper spatio-
temporal physiological environment, as the proteins meet in solution, and the time 
the lysates were allowed to form complexes were 3-4 h under soft rotation, at 4 
degrees. Slow interactions, interactions enabled or supported by other proteins not 
expressed by HEK293 cells, or highly transient interactions might be missed in such 
an approach. However, we could see strong association of wt syntaxin-11 with 
Munc18-2, hence we were confident to test the mutants in this system, too. Of 
course, in this system we consequently may miss out on some variants forming very 
slow or very weak interactions in physiological environments. 
 
 
5.1.1.6 Concluding statement on methodological considerations 
In summary, we are aware that our experimental systems can be optimized further in 
the future. However, given the technological state of the art when we started and 
worked on these projects, we employed well-established methods throughout the 
studies.  
 
 
 
 
  
 
 
 
 
 
 
"You can grunt and heave, sweat and strain, wear yourself out, and 
unless you simply forget about it and step up, you won't even get off the 
ground." 
(Mike Borghoff) 
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That said, I wish I could encourage all of you to keep going your paths, believe in 
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“It is not the rock we conquer but ourselves.” 
(Sr Edmund Hillary) 
 
 
 
 
 
Take care! 
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